<?xml version="1.0" encoding="UTF-8"?>
<svg height="750.471" width="549.4541518421053" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <path d=" M 59.698001861572266 683.60302734375 L 287.5469970703125 683.60302734375 L 287.5469970703125 683.3190307617188 L 59.698001861572266 683.3190307617188" style="fill:none;stroke:#131413;stroke-width:0.0;"/>
  <path d=" M 287.5459899902344 683.60302734375 L 288.0559997558594 683.5460205078125 C 289.3299865722656 683.2030029296875 290.2799987792969 682.4710083007812 290.4939880371094 681.1080322265625 L 290.5509948730469 680.5980224609375 L 290.3240051269531 680.5980224609375 L 290.2669982910156 681.052001953125 C 290.10198974609375 682.114013671875 289.1449890136719 683.1300048828125 288.0559997558594 683.2630004882812 L 287.5459899902344 683.3200073242188" style="fill:none;stroke:#131413;stroke-width:0.0;"/>
  <path d=" M 290.5509948730469 680.5980224609375 L 290.5509948730469 671.0170288085938 L 290.3240051269531 671.0170288085938 L 290.3240051269531 680.5980224609375" style="fill:none;stroke:#131413;stroke-width:0.0;"/>
  <path d=" M 290.5509948730469 671.0170288085938 L 290.4939880371094 670.5070190429688 C 290.39300537109375 669.375 289.1929931640625 668.1510009765625 288.0559997558594 668.0690307617188 L 287.5459899902344 668.0120239257812 L 287.5459899902344 668.2960205078125 L 288.0559997558594 668.2960205078125 C 289.19000244140625 668.6070556640625 290.0489807128906 669.3860473632812 290.26800537109375 670.5630493164062 L 290.3240051269531 671.0170288085938" style="fill:none;stroke:#131413;stroke-width:0.0;"/>
  <path d=" M 287.5459899902344 668.0120239257812 L 59.696990966796875 668.0120239257812 L 59.696990966796875 668.2950439453125 L 287.5459899902344 668.2950439453125" style="fill:none;stroke:#131413;stroke-width:0.0;"/>
  <path d=" M 59.697998046875 668.0120239257812 L 59.1879997253418 668.0690307617188 C 58.05099868774414 668.1510009765625 56.85099792480469 669.375 56.75 670.5060424804688 L 56.692996978759766 671.0170288085938 L 56.91999816894531 671.0170288085938 L 56.97699737548828 670.5630493164062 C 57.1879997253418 669.3910522460938 58.090999603271484 668.5530395507812 59.24399948120117 668.2950439453125 L 59.697998046875 668.2950439453125" style="fill:none;stroke:#131413;stroke-width:0.0;"/>
  <path d=" M 56.692996978759766 671.0170288085938 L 56.692996978759766 680.5980224609375 L 56.91999816894531 680.5980224609375 L 56.91999816894531 671.0170288085938" style="fill:none;stroke:#131413;stroke-width:0.0;"/>
  <path d=" M 56.692996978759766 680.5980224609375 L 56.749996185302734 681.1080322265625 C 56.96399688720703 682.4710083007812 57.91299819946289 683.2020263671875 59.18699645996094 683.5460205078125 L 59.697998046875 683.60302734375 L 59.697998046875 683.3190307617188 L 59.18699645996094 683.2630004882812 C 58.09799575805664 683.1300048828125 57.141998291015625 682.114013671875 56.97599792480469 681.051025390625 L 56.91999816894531 680.5980224609375" style="fill:none;stroke:#131413;stroke-width:0.0;"/>
  <text x="56.693,63.336,69.444,75.552,78.333,82.082,84.863,90.879,96.883,102.24,105.021,108.114,111.543,114.324,117.105" y="104.49199999999996" svg_rhmargin="122.461" style="fill:#131413;font-family:FCMICI+KmmqjcAdvTTaf7f9f4f.B;font-size:10.3px;font-style:NORMAL;font-weight:normal;">Additional file</text>
  <text svg_rhmargin="118.096" x="61.965,66.803,71.25,75.698,77.723,80.453,82.478,86.767,91.14,95.04,97.06500000000001,99.382,101.88,103.905,105.93,109.83000000000001,112.081,116.221,118.096" y="126.71500000000003" style="fill:#0000ff;font-family:FCMICI+KmmqjcAdvTTaf7f9f4f.B;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Additional file 1: </text>
  <text x="120.359,124.964,127.146,130.499,134.556,138.149,140.485,144.077,147.43,148.99,153.047,156.64,160.622,163.899,167.492,169.738,171.688,175.671,177.85399999999998,180.17,182.435,186.417,190.01,192.245,196.228,200.128,202.393,205.67,209.653,215.742,219.335,222.065,223.31,225.637,227.587,232.425,237.419,241.634,245.69199999999998,247.974,251.567,255.16,257.442,260.562,264.619" y="126.71500000000003" svg_rhmargin="266.569" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Grade evidence for the outcomes. (DOCX 14 kb)</text>
  <text x="56.693,61.455,65.828,70.2,72.855,76.68,80.43,82.305,86.055,88.627,90.502,94.717,98.932" y="153.30399999999997" svg_rhmargin="102.052" style="fill:#131413;font-family:FCMIFK+GvlmdfAdvTT99c4c969;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Abbreviations</text>
  <text x="56.693,60.908,62.468,65.198,66.443,68.711,72.926,76.909,80.891,82.841,84.401,88.459,92.051,96.034,99.311,102.90400000000001,105.221,106.781,110.763,113.028,116.621,118.803,122.156,125.508,127.068,129.798,131.043,133.34,138.178,141.613,145.363,146.608,148.874,153.712,155.272,156.832,160.731,162.996,166.589,170.647,172.968,176.561,180.618,182.178,186.161,189.753,193.811,197.793,199.975,201.535,205.518,209.11,210.35500000000002,212.653,217.49,221.24,224.675,225.92000000000002,228.186,233.024,236.616,240.209,244.267,246.554,249.907,253.499,257.482,261.464,265.364" y="162.26199999999994" svg_rhmargin="268.094" style="fill:#000000;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">CIs: Confidence intervals; DEP: Diluted epinephrine; DVT: Deep venous</text>
  <text x="56.693,58.958,62.94,65.123,69.105,75.195,79.253,83.235,85.965,87.525,90.255,91.5,93.826,98.821,103.194,104.43900000000001,106.695,111.69,114.42,116.685,120.278,124.26,127.613,129.795,132.06,136.043,138.225,139.785,142.05,143.716,146.446,147.691,149.952,153.702,157.917,161.352,164.082,165.327,167.583,171.333,174.686,178.668,182.726,186.708,192.798,194.358,197.321,200.913,204.971,207.268,210.545,214.528,218.51,220.775,223.028,227.01,228.57,230.13,233.723,237.781,240.035,242.3,244.483,246.043,249.395,250.955,253.685,254.93,257.213,260.963,264.713,265.958,268.212,271.962,273.522,276.252" y="171.27599999999995" svg_rhmargin="279.372" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">thrombosis; OA: Osteoarthritis; RCTs: Randomized controlled trials; RR: Risk</text>
  <text x="56.693,58.875,62.228,64.493,66.053,70.035,71.28,73.587,77.022,81.71,86.082,87.327,89.575,93.01,96.992,99.257,102.609,104.169,106.469,110.451,112.011,116.06899999999999,118.318,121.671,123.853,126.118,130.1,132.283,136.265,140.323,141.883,145.235,147.965,150.23,153.508,154.75300000000001,157.096,160.53,164.588,168.96,170.205,172.459,175.894,178.076,181.429,185.411,189.004,192.206,195.647,201.736,203.296,206.57399999999998,208.799,212.152,215.429,216.989,221.046,222.291,224.616,230.706,236.481,241.319,242.564,244.856,250.946,254.538,256.098,260.155,264.138,266.403,269.995" y="180.28999999999996" svg_rhmargin="274.052" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">ratio; THA: Total hip arthroplasty; TXA: Tranexamic acid; WMD: Weighted</text>
  <text x="56.693,62.783,66.375,69.728,73.711,75.968,80.026,81.586,83.536,85.486,89.078,91.261,94.853,98.929,102.206" y="189.30399999999997" svg_rhmargin="105.798" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">mean difference</text>
  <text x="56.693,61.455,65.205,68.955,70.83,72.705,76.455,80.828,82.703,84.577,86.452,89.025,92.775,95.074,99.289,101.629,103.917,108.207,111.957,114.53,118.28,120.528,124.278,128.493,132.783,135.041,141.364,145.114,147.686,151.511,154.166,156.041,159.791,161.743" y="210.62" svg_rhmargin="164.863" style="fill:#131413;font-family:FCMIFK+GvlmdfAdvTT99c4c969;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Availability of data and materials</text>
  <text x="56.693,60.128,64.028,68.085,72.143,76.125,78.308,80.573,82.133,86.115,90.173,92.466,96.523,99.876,102.141,105.49300000000001,107.773,109.333,112.063,114.35,117.702,121.055,124.407,125.967,127.527,130.88,134.937,136.497,140.09" y="219.57799999999997" svg_rhmargin="141.335" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Supporting data is available.</text>
  <text x="56.693,61.455,65.67,68.243,72.458,76.673,79.328" y="240.894" svg_rhmargin="82.448" style="fill:#131413;font-family:FCMIFK+GvlmdfAdvTT99c4c969;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Authors</text>
  <text svg_rhmargin="84.205" x="82.488,84.206" y="240.894" style="fill:#131413;font-family:FCPGCO+XknjjcAdvTT99c4c969+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">’ </text>
  <text x="86.456,89.809,94.024,98.239,100.811,103.466,105.341,109.713,113.928,116.501,118.376,122.591,126.806" y="240.894" svg_rhmargin="129.926" style="fill:#131413;font-family:FCMIFK+GvlmdfAdvTT99c4c969;font-size:7.5px;font-style:NORMAL;font-weight:normal;">contributions</text>
  <text x="56.692,60.675,66.765,69.051,73.109,76.701,79.431,80.991,85.049,89.031,92.623,96.68100000000001,98.985,101.25,105.232,108.825,111.06,113.79,116.055,119.955,124.013,127.29100000000001,129.599,132.951,136.934,140.992,143.261,147.319,150.911,154.264,157.856,159.416,163.398,167.456,171.048,175.106,177.39,179.655,183.638,187.231,189.522,191.705,195.297,197.562,199.744,201.304,204.897,208.249,211.602,213.162,215.431,218.161,220.425,222.608,225.96,228.225,231.818,235.875,239.241,240.48600000000002,242.699,246.682,252.772,255.059,258.411,262.393,266.45099999999996,268.721,273.409,275.981" y="249.90800000000002" svg_rhmargin="279.963" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">ZW designed the study and developed the retrieval strategy. ZW and HJZ</text>
  <text x="56.692,59.422,63.015,66.367,68.549,71.827,75.809,79.402,83.46000000000001,85.775,89.128,93.11,97.168,99.438,102.168,105.445,107.628,111.22,114.813,118.795,122.387,126.445,128.747,131.012,134.995,138.588,140.823,143.553,147.453,153.543,159.633,162.985,165.258,166.818,170.41,173.14,175.406,178.758,182.741,186.799,189.068,191.333,192.893,195.158,196.718,200.311,203.041,204.286,206.53,211.217,213.79,217.773,220.079,223.431,227.414,231.47199999999998,233.742,237.724,243.814,246.044,250.101,252.284,255.636,257.586,259.851,263.443,267.501,269.798,272.063,276.046" y="258.923" svg_rhmargin="279.638" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">searched and screened the summaries and titles. HJZ and ZW drafted the</text>
  <text x="56.692,60.045,62.227,64.492,66.052,69.329,70.889,74.482,75.727,78.008,81.758,85.741,88.006,91.989,94.279,97.632,101.532,103.797,107.779,111.762,113.944,116.674,118.941,121.123,124.715,128.068,132.126,134.417,137.77,141.752,145.81,148.08,151.432,155.49,159.547,161.73,165.712,169.065,172.657,176.715,179.034,181.299,185.282,188.875,191.166,193.116,194.676,198.659,202.011,203.571,205.849,209.907,212.089,215.442,217.392,219.657" y="267.88" svg_rhmargin="220.902" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">article. Both authors read and approved the final draft.</text>
  <text x="56.692,60.517,63.09,67.304,69.179,72.532,75.652,77.952,81.702,86.074,90.447,93.102,97.317,101.067,104.817,106.692,108.963,112.713,116.928,121.218,123.476,126.828,131.043,135.258,138.378,142.203,146.418,148.99,151.312,153.884,158.099,160.383,164.755,168.505,171.16,173.733,175.608,178.96,180.835,185.207,188.957,191.53" y="289.197" svg_rhmargin="195.355" style="fill:#131413;font-family:FCMIFK+GvlmdfAdvTT99c4c969;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Ethics approval and consent to participate</text>
  <text x="56.692,60.127,64.11,65.669,68.399,70.695,72.255,74.985,77.215,80.56700000000001,82.828,88.918,92.51,94.775,98.128,100.31,103.663,107.645,110.997,112.557,115.936,118.666,120.226,122.956,124.20100000000001,126.424,130.406,134.389,136.685,138.868,142.46,144.02,147.613,150.965,154.318,158.3,160.565,162.877,166.935,169.117,173.1,177.157,178.717,182.309,188.399,191.129,193.434,197.027,200.229,201.789,204.519,206.784" y="298.211" svg_rhmargin="208.029" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">This is a meta-analysis; no relevant problems exist.</text>
  <text x="56.692,61.065,65.279,69.494,72.614,76.439,80.654,83.226,85.549,87.889,92.104,94.759,97.0,101.373,105.588,109.96,111.835,113.71,117.063,120.813,123.385,125.26,129.475" y="319.527" svg_rhmargin="133.69" style="fill:#131413;font-family:FCMIFK+GvlmdfAdvTT99c4c969;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Consent for publication</text>
  <text x="56.692,61.455,65.437,67.702,69.958,73.31,77.368,81.425,82.985,84.545,87.823,91.175,95.233,96.793,100.385" y="328.541" svg_rhmargin="101.63" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Not applicable.</text>
  <text x="56.692,61.065,65.279,71.602,75.974,79.799,82.372,84.247,88.462,92.75200000000001,95.073,96.948,101.163,103.735,107.56,110.215,114.04,117.16,119.733" y="349.857" svg_rhmargin="122.853" style="fill:#131413;font-family:FCMIFK+GvlmdfAdvTT99c4c969;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Competing interests</text>
  <text x="56.692,60.442,64.425,66.689,70.672,72.963,76.316,80.216,82.481,86.463,90.445,92.628,95.358,97.624,101.682,105.274,108.552,110.112,113.464,115.647,119.24000000000001,121.548,123.813,127.796,131.148,133.41299999999998,135.665,137.93,141.912,145.504,148.78199999999998,151.085,155.068,158.42,161.772,165.36499999999998,167.64,171.622,175.60500000000002,177.844,181.121,185.104,191.194,195.251,198.844,201.109,202.669,206.651,210.709,212.993,214.553,218.535,220.8,224.393,226.575,230.168,232.898,235.163,237.893" y="358.814" svg_rhmargin="239.138" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Both authors declare that they have no competing interests.</text>
  <text x="56.693,62.584,68.476,74.584,77.365,80.146,84.544,90.549,95.905" y="386.142" svg_rhmargin="99.768" style="fill:#131413;font-family:FCMICI+KmmqjcAdvTTaf7f9f4f.B;font-size:10.3px;font-style:NORMAL;font-weight:normal;">Publisher</text>
  <text x="99.893" y="386.142" svg_rhmargin="102.468" style="fill:#131413;font-family:FCPGCP+NwlxtrAdvTTaf7f9f4f.B+20;font-size:10.3px;font-style:NORMAL;font-weight:normal;">’</text>
  <text x="102.444,106.842,109.928,117.005,122.968,126.717" y="386.142" svg_rhmargin="132.073" style="fill:#131413;font-family:FCMICI+KmmqjcAdvTTaf7f9f4f.B;font-size:10.3px;font-style:NORMAL;font-weight:normal;">s Note</text>
  <text x="56.693,60.128,64.006,66.189,67.578,71.56,75.458,79.05,81.233,83.111,87.76,91.113,93.203,97.103,99.156,102.74900000000001,104.655,106.837,110.268,116.358,119.565,121.125,124.951,127.681,129.599,133.582,137.026,140.926,143.036,145.218,148.365,149.925,151.88,157.265,158.683,160.948,164.931,166.734,168.916,172.347,176.404,179.604,181.786,185.844,187.711,189.976,193.959,195.818,197.378,201.091,203.273,204.662,207.392,211.295,212.855,216.001,218.266,219.629,223.611,227.396,230.748,232.308,234.199,237.477,238.848,242.2,243.61,249.7,252.42999999999998,254.268,255.828,259.811,261.695,265.753,269.462,273.52,274.905,276.465,279.043,283.026,286.47" y="395.156" svg_rhmargin="290.527" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Springer Nature remains neutral with regard to jurisdictional claims in published</text>
  <text x="56.693,62.783,65.991,70.048,72.778,74.608,77.96,81.808,85.86600000000001,87.818,89.377,93.147,95.877,97.966,99.526,101.65,105.55,107.66,109.22,112.989,116.972,120.189,121.749,123.705,126.936,128.886,130.678,132.238,133.626,135.186,138.389,140.654,142.017,145.999,149.841,152.449" y="404.17" svg_rhmargin="153.694" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">maps and institutional affiliations.</text>
  <text x="56.693,61.455,65.67,68.243,72.458,76.673,79.328,81.638,85.928,89.752,92.325,96.075,97.95,99.825" y="422.142" svg_rhmargin="102.945" style="fill:#131413;font-family:FCMIFK+GvlmdfAdvTT99c4c969;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Author details</text>
  <text x="56.693" y="427.811" svg_rhmargin="59.387" style="fill:#000000;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:5.0px;font-style:NORMAL;font-weight:normal;">1</text>
  <text x="59.357,64.195,67.787,71.845,75.197,77.38,79.645,85.833,89.425,93.408,95.673,97.908,101.891,103.84100000000001,106.129,111.124,113.307,115.571,119.554,123.536,127.594,131.186,135.244,136.804,140.081,142.811,144.056,146.38,148.953,150.513,154.495,158.553,160.113,161.673,165.025,169.008,173.066,175.35,179.1,182.693,186.675,190.733,192.292" y="431.156" svg_rhmargin="195.884" style="fill:#000000;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Department of Orthopedics, Jingjiang People</text>
  <text x="195.931" y="431.156" svg_rhmargin="197.176" style="fill:#000000;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">’</text>
  <text x="197.178,199.908,202.167,206.854,210.837,213.567,217.624,219.184,221.449,224.802,226.362,227.607,229.889,232.462,234.022,238.004,242.062,243.622,245.182,248.534,252.517,256.574,257.819,260.163,264.378,268.36,269.92,273.903,277.255" y="431.156" svg_rhmargin="278.5" style="fill:#000000;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">s Hospital, Jingjiang, China.</text>
  <text x="56.693" y="436.825" svg_rhmargin="59.387" style="fill:#000000;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:5.0px;font-style:NORMAL;font-weight:normal;">2</text>
  <text x="59.357,64.195,67.787,71.845,75.197,77.38,79.645,85.833,89.425,93.408,95.673,97.908,101.891,103.84100000000001,106.129,111.124,113.307,115.571,119.554,123.536,127.594,130.946,134.539,138.596,140.156,143.434,146.164,147.409,149.725,153.16,157.143,160.736,162.991,166.584,170.176,172.358,176.341,178.638,183.326,187.308,190.038,194.095,195.655,197.92,201.273,202.833,205.114,209.096,211.046,213.277,217.027,220.62,224.602,228.66,230.219" y="440.17" svg_rhmargin="233.811" style="fill:#000000;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Department of Orthopaedics, The 82rn Hospital of People</text>
  <text x="233.858" y="440.17" svg_rhmargin="235.103" style="fill:#000000;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">’</text>
  <text x="235.106,237.83599999999998,240.095,243.447,245.007,249.064,252.657,254.839,258.192,260.457,262.017,265.999,269.982,272.296,276.669,278.851,284.941" y="440.17" svg_rhmargin="288.218" style="fill:#000000;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">s Liberation Army</text>
  <text x="56.693,60.675,62.625,64.913,69.128,73.111,74.671,78.653,82.006,83.251,85.492,90.255,94.237,95.482,97.794,101.387,104.979,108.572,109.81700000000001,112.081,114.653,116.213,119.566,123.548,126.668,130.021,134.003,138.061,142.118,146.101,150.083,154.141,156.471,160.221,164.203,167.556,171.613,172.858,175.122,179.81,183.71,187.062" y="449.127" svg_rhmargin="188.622" style="fill:#000000;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">of China, No. 100, Jiankangdong Road, Huai</text>
  <text x="188.674" y="449.127" svg_rhmargin="189.919" style="fill:#000000;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">’</text>
  <text x="189.921,193.273,197.256,198.501,200.749,203.322,204.882,208.234,212.217,216.274,219.004,222.904,224.149,226.488,230.702,234.685,236.245,240.227,243.58" y="449.127" svg_rhmargin="244.825" style="fill:#000000;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">an, Jiangsu, China.</text>
  <text x="56.693,60.675,64.425,67.778,71.528,73.245,76.838,80.587,84.802,86.27900000000001,88.554,92.379,96.20400000000001,98.475,101.205,105.262,106.98,110.49000000000001,112.761,116.586,120.411,124.236,128.061,130.336,134.866,138.218,141.571,145.321,149.611,152.026,155.776,159.991,161.46800000000002,163.728,167.553,171.378,173.648,177.316,181.066,185.281,187.696,191.446,197.693,201.908,205.658,208.07299999999998,210.385,214.21,218.035,221.86" y="467.156" svg_rhmargin="225.685" style="fill:#131413;font-family:FCMIFI+GghxhkAdvTTe45e47d2;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Received: 19 July 2018 Accepted: 11 September 2018</text>
  <path d="M59.698 116.396 L287.546 116.396 L287.546 116.68 L59.698 116.68 M287.545 116.396 L288.055 116.453 C289.33 116.796 290.28 117.528 290.494 118.891 L290.55 119.401 L290.324 119.401 L290.266 118.947 C290.102 117.885 289.145 116.869 288.056 116.736 L287.545 116.679 M290.55 119.401 L290.55 128.982 L290.324 128.982 L290.324 119.401 M290.55 128.982 L290.493 129.492 C290.393 130.625 289.193 131.848 288.056 131.93 L287.545 131.987 L287.545 131.703 L288.055 131.703 C289.19 131.392 290.048 130.613 290.268 129.436 L290.324 128.982 M287.545 131.987 L59.696 131.987 L59.696 131.704 L287.545 131.704 M59.697 131.987 L59.187 131.93 C58.051 131.848 56.85 130.625 56.75 129.493 L56.692 128.982 L56.919 128.982 L56.976 129.436 C57.188 130.608 58.091 131.446 59.244 131.704 L59.697 131.704 M56.692 128.982 L56.692 119.401 L56.919 119.401 L56.919 128.982 M56.692 119.401 L56.749 118.891 C56.963 117.528 57.913 116.797 59.186 116.453 L59.697 116.396 L59.697 116.68 L59.186 116.736 C58.097 116.869 57.142 117.885 56.975 118.948 L56.919 119.401 M56.692 468.856 L188.673 468.856 L188.673 479.627 L56.692 479.627 " style="fill:none;stroke:#131413;stroke-width:0.0;"/>
  <rect style="stroke:blue;stroke-width:0.3;" x="56.693" y="468.857" height="10.8" width="131.999" title="11"/>
  <text x="56.693" y="468.857" class="image" id="image.11.1" width="131" height="10">image.11.1.57_189.469_480</text>
  <text x="56.693,60.908,64.733,67.073,70.898,73.553,77.378,81.593,84.945,88.77" y="497.487" svg_rhmargin="91.89" style="fill:#131413;font-family:FCMIFK+GvlmdfAdvTT99c4c969;font-size:7.5px;font-style:NORMAL;font-weight:normal;">References</text>
  <text x="56.693,60.106,61.289,71.716,76.091,79.796,83.57900000000001,85.72,90.173,91.35600000000001,93.487,99.272,102.457,106.24,110.095,112.251,116.256,117.43900000000001,119.564,124.018,127.431,129.542,133.105,134.28799999999998,136.458,140.612,142.751,148.536,151.949,154.101,157.286,159.359,162.544,166.327,169.512,170.994,174.108,176.701,178.183,180.77599999999998,182.945,186.358,189.543,192.728,194.21,197.915,201.1,203.251,206.664,209.25699999999998,211.404,213.556,217.339,220.752,222.913,226.326,228.179,230.031,231.513,234.627,237.811,240.925,244.03900000000002,246.157,249.94,251.792,253.924,255.406,259.189,261.341,263.414,266.599,269.784,273.197,276.98,280.763,284.468" y="506.444" svg_rhmargin="287.061" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">1. Guo H, Wang C, He Y. A meta-analysis evaluates the efficacy of intravenous</text>
  <text x="71.716,74.901,78.015,81.428,83.579,86.764,92.55,94.032,97.815,101.598,105.453,109.236,112.649,116.432,118.543,120.396,124.179,126.252,128.408,132.262,135.447,136.929,140.712,142.864,148.65,151.835,155.618,158.803,162.657,166.07,171.855,175.268,179.052,181.20399999999998,183.342,184.824,188.607,190.769,193.733,197.517,200.929,204.342,206.473,210.257,212.33,214.467,218.25,219.732,223.587,225.748,228.933,231.006,233.158,236.941,239.015,242.798,246.653,248.135,251.32,253.913,256.065,259.178,260.361,262.541,264.985,267.133,271.878,273.952,276.104,279.887,283.67" y="515.4580000000001" svg_rhmargin="287.525" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">acetaminophen for pain management in knee or hip arthroplasty. J Orthop</text>
  <text x="71.716,74.98,78.093,79.575,80.75800000000001,82.885,86.298,89.71,93.123,96.536,97.719,101.132,104.544,106.397,109.81,111.662,112.845,116.258,119.671" y="524.472" svg_rhmargin="123.084" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Sci. 2018;23(5):793</text>
  <text x="123.081" y="524.472" svg_rhmargin="126.643" style="fill:#131413;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="126.652,130.065,133.478,136.891" y="524.472" svg_rhmargin="138.074" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">800.</text>
  <text x="56.693,60.106,61.289,71.716,75.201,78.905,80.979,83.131,85.945,88.1,91.363,92.546,94.676,99.422,103.205,107.06,109.19,112.674,113.85700000000001,115.993,119.178,122.362,126.067,128.238,131.502,132.685,134.815,140.301,144.084,149.2,152.385,154.53699999999998,156.697,159.96,161.143,163.274,167.727,170.911,172.393,176.248,179.661,181.734,185.517,187.651,193.137,194.32,196.495,200.057,202.131,205.914,207.396,210.809,213.922,216.074,217.556,221.339,225.123,227.71599999999998,229.829,233.613,235.465,237.653,241.508,243.581,245.063,250.849,254.033,256.107,259.221,261.351,264.536,268.319" y="533.4870000000001" svg_rhmargin="272.174" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">2. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and</text>
  <text x="71.716,73.79,77.203,80.387,81.869,84.463,85.945,89.728,93.511,95.64,99.424,100.906,104.76100000000001,106.922,110.107,113.89,117.745,119.848,122.812,126.595,130.008,133.42100000000002,135.608,138.793,140.866,143.018,146.802,148.875,152.658,156.513,157.995,161.18,163.773,165.925,169.03900000000002,171.154,172.636,176.41899999999998,178.581,180.732,184.516,187.929,190.09,194.543,198.326,199.808,201.96,205.372,209.227,211.349,214.612,216.764,219.949,222.1,225.513,228.106,230.227,232.079,234.153,237.936,243.721,245.874,249.287,252.7,256.112,259.52500000000003,261.691,263.843,267.62600000000003,269.742,273.155,276.567,279.98,283.393,284.57599999999996,286.75" y="542.444" svg_rhmargin="289.194" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">revision hip and knee arthroplasty in the United States from 2005 to 2030. J</text>
  <text x="71.716,75.279,79.062,82.846,86.259,88.384,90.828,94.611,96.093,99.876,102.028,104.144,107.407,111.112,113.186,117.04100000000001,119.224,123.378,129.163,130.346,132.49,135.903,139.315,142.728,146.141,147.324,150.737,154.149,156.002,159.415,161.267,162.45,165.863,169.276" y="551.458" svg_rhmargin="172.689" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Bone Joint Surg Am. 2007;89(4):780</text>
  <text x="172.687" y="551.458" svg_rhmargin="176.249" style="fill:#131413;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="176.259,179.672" y="551.458" svg_rhmargin="180.855" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">5.</text>
  <text x="56.693,60.106,61.289,71.716,74.901,76.383,80.088,82.204,86.949,88.132,90.311,94.686,98.099,101.882,105.73700000000001,107.829,111.391,112.57400000000001,114.745,118.008,121.792,123.274,125.403,128.588,129.771,131.923,137.708,140.893,144.676,148.53099999999998,150.687,155.433,156.61599999999999,158.738,164.523,167.708,171.491,175.346,177.503,181.065,182.248,184.363,187.626,189.699,192.884,196.667,200.08,203.122,206.307,212.093,213.575,216.689,218.888,222.073,225.186,226.668,230.523,232.664,235.849,239.261,241.335,243.928,247.633" y="560.472" svg_rhmargin="250.226" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">3. Liu Q, Geng P, Shi L, Wang Q, Wang P. Tranexamic acid versus</text>
  <text x="71.716,74.901,80.687,82.169,85.952,89.735,92.849,96.034,99.888,101.962,105.745,107.227,110.34100000000001,112.478,115.663,118.776,120.258,124.113,126.254,128.106,131.89,133.963,136.118,139.973,141.455,145.238,149.022,152.87699999999998,154.997,160.782,163.967,167.75,170.935,174.79,178.202,183.988,187.401,191.184,193.33599999999998,195.531,198.716,200.568,202.72,206.133,208.20600000000002,210.327,212.479,216.262,218.414,221.599,223.081,225.237,228.201,231.985,235.398,238.811,240.941,244.126,247.91,251.765,253.924,256.075,259.859,262.01,265.195,266.677,268.834,272.617,274.099" y="569.486" svg_rhmargin="277.954" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">aminocaproic acid for blood management after total knee and total hip</text>
  <text x="71.716,74.901,76.975,79.126,82.91,84.983,88.766,92.621,94.103,97.288,99.881,102.033,105.146,106.32900000000001,108.452,111.637,113.782,116.375,119.489,122.082,124.234,127.647,133.432,136.617,138.769,140.251,143.365,145.529,147.602,151.015,154.2,155.682,159.095,164.211,166.391,169.576,173.36,177.215,179.317,185.103,188.516,190.667,193.852,195.926,199.11,202.894,206.079,207.561,210.674,213.268,214.75,217.343,218.52599999999998,220.702,222.184,225.968,228.11999999999998,230.283,232.72699999999998,234.875,238.138,241.843,243.917,247.771,248.95399999999998,251.089,254.502,257.915,261.328,264.741,265.923,269.336,272.749,274.602,278.164,280.316,282.44,286.594,288.446" y="578.443" svg_rhmargin="289.629" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">arthroplasty: a systematic review and meta-analysis. Int J Surg. 2018;54(Pt A):</text>
  <text x="71.716,75.129,78.542" y="587.457" svg_rhmargin="81.955" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">105</text>
  <text x="81.921" y="587.457" svg_rhmargin="85.483" style="fill:#131413;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="85.493,88.906,92.319" y="587.457" svg_rhmargin="93.502" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">12.</text>
  <text x="56.693,60.106,61.289,71.716,74.901,76.383,78.519,80.963,84.226,85.409,87.533,90.718,92.2,94.336,98.789,99.97200000000001,102.103,105.886,109.669,112.854,116.637,118.827,123.28,124.46300000000001,126.594,132.379,135.564,139.347,143.202,145.359,147.803,148.986,151.085,154.27,155.752,159.45700000000002,161.63,164.893,166.076,168.206,171.469,175.253,179.036,182.891,185.044,188.606,189.789,191.904,197.689,201.394,203.582,208.035,211.298,212.481,214.58,218.584,222.367,228.153,232.007,233.489,237.273,240.686,244.541,246.724,250.429,253.022,256.435,258.573,262.356" y="596.472" svg_rhmargin="264.208" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">4. Li JF, Li H, Zhao H, Wang J, Liu S, Song Y, Wu HF. Combined use of</text>
  <text x="71.716,73.198,76.982,79.133,81.207,84.392,87.576,90.989,94.773,98.556,102.261,104.854,106.978,110.163,113.946,117.801,119.961,122.112,125.896,129.75,131.232,134.346,137.531,139.013,141.164,144.348,147.761,149.835,152.428,156.133,158.726,160.892,162.374,166.158,168.309,170.383,173.568,176.752,180.165,183.949,187.732,191.437,194.03,196.154,198.306,200.379,203.564,207.347,210.76,213.803,216.987,222.773,224.255,227.369,229.546,232.731,235.844,237.326,241.18099999999998,243.322,244.804,248.587,250.749,254.603,256.677,258.159,263.944,267.129,269.202,272.316,274.446,276.598,280.381,282.533,285.718" y="605.486" svg_rhmargin="287.2" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">intravenous and topical versus intravenous tranexamic acid in primary total</text>
  <text x="71.716,74.68,78.464,81.877,85.28999999999999,87.42,90.605,94.389,98.244,100.403,104.186,105.668,109.52300000000001,111.628,114.813,116.886,119.038,122.821,124.895,128.678,132.532,134.014,137.199,139.793,141.944,145.058,146.24099999999999,148.421,151.606,153.75,159.536,162.949,165.1,168.285,170.359,173.543,177.327,180.512,181.994,185.107,187.701,189.183,191.77599999999998,193.945,197.728,199.58,201.712,203.785,206.97,210.753,214.608,218.391,224.177,225.658,228.252,231.665,235.51999999999998,237.711,240.825,244.608,248.391,250.543,252.616,256.4,257.882,259.364,262.776,266.63100000000003,268.778,270.929,273.003,274.485,277.67,279.152,281.745,282.928,285.048" y="614.443" svg_rhmargin="287.492" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">knee and hip arthroplasty: a meta-analysis of randomised controlled trials. J</text>
  <text x="71.716,76.462,78.535,80.687,84.47,88.253,92.108,94.223,97.487,101.191,103.265,107.12,109.303,112.866,116.278,118.872,120.055,122.172,125.585,128.998,132.411,135.823,137.006,140.419,143.832,145.684,149.097,150.95,152.132,155.545,158.958" y="623.457" svg_rhmargin="160.141" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Orthop Surg Res. 2017;12(1):22.</text>
  <text x="56.693,60.106,61.289,71.716,74.901,76.383,78.519,82.082,84.526,85.709,87.817,91.671,95.376,97.568,101.13,104.393,105.57600000000001,107.716,111.278,114.463,115.945,118.09,121.353,124.916,126.099,128.238,132.613,136.318,140.101,142.242,146.096,148.54,149.72299999999998,151.879,155.442,158.627,162.41,164.522,168.376,171.939,173.12199999999999,175.293,178.556,182.34,185.75300000000001,187.879,191.292,193.144,194.996,196.478,199.592,202.777,205.89,209.004,211.122,214.906,216.758,218.946,220.428,224.211,226.363,228.437,231.621,234.806,238.219,242.002,245.786,249.491" y="632.471" svg_rhmargin="252.084" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">5. Li YJ, Xu BS, Bai SP, Guo XJ, Yan XY. The efficacy of intravenous</text>
  <text x="71.716,74.901,80.687,82.169,85.952,89.735,92.849,96.034,99.888,101.962,105.745,107.227,110.34100000000001,112.478,115.663,118.776,120.258,124.113,126.254,127.736,131.519,133.681,137.536,139.609,141.091,146.876,150.061,152.134,155.248,157.378,159.53,163.313,165.465,168.65,170.132,172.289,176.072,177.554,181.409,183.57,186.755,190.538,194.393,196.553,199.516,203.3,206.713,210.126,212.257,215.441,217.515,219.666,223.45,225.523,229.306,233.161,234.643,237.828,240.421,242.573,245.687,246.87,248.993,252.178,254.322,260.107,263.52,265.672,268.857" y="641.485" svg_rhmargin="270.93" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">aminocaproic acid in primary total hip and knee arthroplasty: a meta-</text>
  <text x="71.716,74.901,78.685,81.869,83.351,86.465,89.058,90.54,93.134,94.31700000000001,96.434,98.878,101.026,105.771,107.845,109.996,113.78,117.563,121.418,123.589,126.852,130.557,132.631,136.486,138.613,142.175,145.588,148.182,149.36499999999998,151.539,154.952,158.365,161.777,165.19,166.373,169.786,173.199,175.051,178.464,180.316,181.499,184.912,188.325" y="650.442" svg_rhmargin="189.508" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">analysis. J Orthop Surg Res. 2018;13(1):89.</text>
  <text x="56.693,60.106,61.289,71.716,75.279,76.761,80.544,83.658,87.441,89.574,92.838,98.324,99.507,101.65,103.132,106.915,110.769,112.843,116.028,121.813,123.93,127.934,129.117,131.3,135.753,139.458,140.94,142.422,144.566,147.01,148.19299999999998,150.348,153.611,156.796,161.912,165.026,168.731,171.32399999999998,173.479,176.742,177.92499999999998,180.055,184.209,187.992,190.144,193.927,197.71,201.494,204.608,206.757,209.201,210.384,212.482,216.857,218.93,222.343,225.756,229.539,231.613,234.876,238.659,242.443,248.228,252.083,254.676,258.459,262.242,264.412,267.975" y="659.456" svg_rhmargin="269.158" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">6. Bloch EM, Ingram C, Hull J, Fawcus S, Anthony J, Green-Thompson R,</text>
  <text x="71.716,75.721,77.794,81.577,85.361,88.325,91.737,94.33,96.434,99.997,103.181,104.364,106.525,111.049,114.904,118.018,121.801,125.656,129.439,131.583,134.846,136.029,138.159,141.72199999999998,143.885,147.889,149.963,153.376,156.788,158.27,160.382,164.978,166.161,168.319,172.324,176.107,179.812,181.885,184.037,187.82,191.233,194.347,196.495,199.68,200.863,203.014,206.427,208.57899999999998,210.724,213.909,215.391,216.57399999999998,218.717,222.28,223.762,226.355,229.319,231.473,233.326,236.51,239.624,241.776,245.559,247.632,250.225,252.393,254.245,258.028" y="668.471" svg_rhmargin="260.101" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Crookes RL, Ngcobo S, V Creel D, Courtney L, et al. Risk factors for</text>
  <text x="71.716,75.571,78.984,81.057,82.539,86.394,89.579,91.652,93.804,97.509,103.294,105.448,109.302,110.784,114.568,118.351,122.206,124.326,126.478,128.551,131.736,135.519,138.113,139.965,143.67,146.264,147.746,151.529,155.31199999999998,157.49,158.972,162.755,164.86,168.123,171.907,175.612,177.763,181.546,183.738,187.892,189.745,191.818,193.3,196.414,199.598,200.781,202.9,206.085,208.23,211.343,214.528,217.121,220.534,222.608,225.721,229.505,233.288,235.44,237.513,241.296,242.778,244.966,247.559,249.711,253.416,257.27,260.384" y="677.485" svg_rhmargin="261.567" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">peripartum blood transfusion in South Africa: a case-control study.</text>
  <text x="71.716,74.98,77.053,80.238,84.021,86.615,88.467,92.172,94.766,96.247,100.031,103.814,104.997,107.149,110.561,113.974,117.387,120.8,121.983,123.835,127.098,130.953,134.658,138.51299999999998,140.653,143.838,147.622,151.034,154.219,158.07399999999998,160.212,163.995,165.847,167.979,171.833,173.907,175.389,179.172,181.324,183.176" y="686.443" svg_rhmargin="184.359" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Transfusion. 2018;[Epub ahead of print].</text>
  <text x="56.693,60.106,61.289,71.716,76.091,77.573,80.758,84.541,87.726,90.69,94.473,97.066,99.212,103.366,106.551,107.73400000000001,109.87,114.323,118.028,120.102,121.584,124.996,128.10999999999999,130.28,133.543,136.806,137.989,140.087,144.54,147.725,149.798,151.28,155.064,158.91899999999998,161.12,164.682,167.945,169.128,171.268,174.83,178.613,182.397,186.17999999999998,188.276,191.838,195.101,196.284,198.424,201.608,203.09,206.945,210.728,212.802,215.986,219.1,222.513,224.672,227.935,232.089,233.272,235.443,239.006,242.418,246.273,249.978,253.092,255.243,256.725,260.509,264.29200000000003,266.454,270.237" y="695.457" svg_rhmargin="272.089" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">7. Gianakos AL, Hurley ET, Haring RS, Yoon RS, Liporace FA. Reduction of</text>
  <text x="71.716,75.571,77.053,80.836,84.62,88.47500000000001,90.595,92.077,95.86,98.453,101.046,103.18,107.035,110.149,112.308,114.459,116.533,119.718,123.501,126.914,129.956,133.141,138.926,140.408,143.522,145.699,148.884,151.998,153.48,157.33499999999998,159.475,161.328,165.111,166.593,168.075,171.858,176.974,178.456,182.239,186.094,188.218,190.37,194.153,196.305,199.489,200.971,203.127,206.911,208.393,212.248,214.409,217.594,221.377,225.232,227.335,230.299,234.082,237.495,240.90800000000002,243.095,246.28,248.353,250.505,254.288,256.362,260.145,264.0,265.482,268.667,271.26,273.412,276.525,277.70799999999997,279.831" y="704.471" svg_rhmargin="283.016" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">blood loss by tranexamic acid following total hip and knee arthroplasty: a</text>
  <text x="71.716,77.502,80.915,83.066,86.251,88.325,91.509,95.293,98.478,99.96,103.073,105.667,107.149,109.742,110.92500000000001,113.101,115.545,119.108,121.552,124.81500000000001,126.934,129.008,132.421,135.605,137.087,140.5,145.616,148.209,149.392,151.539,154.952,158.364,161.777,165.19,166.373,169.786,171.638,175.051,176.903,178.086,181.499,184.912" y="713.485" svg_rhmargin="186.095" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">meta-analysis. JBJS reviews. 2018;6(5):e1.</text>
  <text x="56.693,60.106,61.289,71.716,74.98,77.053,78.535,82.39,86.173,89.358,91.431,94.616,98.399,100.516,104.0,105.183,107.376,110.639,112.121,115.306,118.491,120.564,123.749,129.534,132.719,135.683,137.756,139.238,141.832,145.615,149.399,152.583,156.36599999999999,158.512,162.887,164.07,166.222,169.485,171.558,174.743,178.527,181.939,184.982,188.167,193.952,195.434,198.548,200.691,203.876,206.989,208.471,212.326,214.467,215.949,219.732,221.894,224.045,227.829,229.98,233.165,234.647,236.804,240.587,242.069,245.92399999999998,248.029,251.214,253.287,255.439,259.223,261.296,265.079,268.934,270.416,273.601,276.194,278.346,281.459" y="722.443" svg_rhmargin="282.642" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">8. Sridharan K, Sivaramakrishnan G. Tranexamic acid in total hip arthroplasty:</text>
  <text x="71.716,77.502,78.984,82.026,85.439,89.294,91.388,93.54,95.613,99.026,102.211,104.363,110.148,113.561,117.344,119.496,121.661,124.775,128.558,134.344,138.198,141.383,143.456,144.938,147.532,151.315,155.098,157.691,159.871,163.655,165.507,167.638,169.712,172.896,176.68,180.534,184.318,190.103,191.585,194.399,197.812,201.667,203.808,206.921,210.705,214.488,216.64,218.713,222.496,223.978,225.46,228.873,232.72799999999998,234.875,237.026,239.1,240.582,243.766,245.248,247.84099999999998,250.011,253.196,256.98,260.83500000000004,262.994,266.107,269.891,273.674,277.457,279.531" y="731.457" svg_rhmargin="281.683" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">mixed treatment comparisons of randomized controlled trials and cohort</text>
  <text x="71.716,74.31,76.462,80.167,84.021,85.503,88.916,91.509,92.69200000000001,94.847,97.291,99.439,104.184,106.257,108.409,112.192,115.976,119.83,121.013,123.136,126.549,129.962,133.375,136.787,137.97,141.383,144.796,146.648,150.061,151.914,153.096,156.509" y="740.471" svg_rhmargin="159.922" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">studies. J Orthop. 2018;15(1):81</text>
  <text x="159.931" y="740.471" svg_rhmargin="163.493" style="fill:#131413;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text svg_rhmargin="168.098" x="163.502,166.915,168.09799999999998" y="104.49000000000001" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">8. </text>
  <text x="304.725,308.138,309.32099999999997,319.749,324.202,327.907,331.091,334.875,338.73,340.838,344.101,345.284,347.472,353.257,356.962,359.094,362.656,363.839,365.954,369.516,370.998,374.781,376.952,380.735,381.918,384.038,389.524,392.709,394.866,399.241,400.424,402.576,406.58,410.364,413.549,417.332,421.187,423.325,425.769,426.952,429.108,433.262,435.401,437.994,441.108,443.701,445.853,449.266,455.051,458.236,460.388,461.87,464.984,467.092,469.165,472.578,475.763,477.245,480.657,485.77299999999997,487.954,491.139,494.922,498.77700000000004,500.936,506.722,510.135,512.286,515.471" y="104.49000000000001" svg_rhmargin="517.544" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">9. Huang F, Wu Y, Yin Z, Ma G, Chang J. A systematic review and meta-</text>
  <text x="319.748,322.933,326.717,329.901,331.383,334.497,337.091,338.572,341.165,343.276,347.059,348.911,351.099,353.251,357.035,360.44800000000004,362.551,366.256,368.85,372.26300000000003,374.4,378.183,380.03499999999997,382.167,385.352,389.135,391.287,392.769,394.621,396.103,399.958,402.031,403.513,407.297,411.08,412.562,415.675,417.827,419.309,422.423,424.629,427.814,431.669,435.082,438.865,441.017,443.61,445.718,447.2,450.983,453.145,455.297,459.08,461.232,464.417,465.899,468.055,471.838,473.32,477.175,479.28,482.465,484.538,486.69,490.473,492.547,496.33,500.185,501.667,504.851,507.445,509.597,512.71,513.893,516.073,520.526,522.008,525.863,528.035,529.517,533.3,535.452" y="113.447" svg_rhmargin="536.635" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">analysis of the use of antifibrinolytic agents in total hip arthroplasty. Hip Int.</text>
  <text x="319.748,323.161,326.574,329.987,333.4,334.583,337.995,341.408,343.261,346.674,348.526,349.709,353.122,356.534" y="122.46100000000001" svg_rhmargin="359.947" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">2015;25(6):502</text>
  <text x="359.944" y="122.46100000000001" svg_rhmargin="363.506" style="fill:#131413;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="363.515,366.928" y="122.46100000000001" svg_rhmargin="368.111" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">9.</text>
  <text x="304.725,308.138,311.551,312.734,319.749,325.534,329.239,331.371,334.933,336.116,338.231,342.014,345.427,349.21,353.065,355.238,358.801,359.984,362.098,365.661,368.846,372.629,374.797,378.652,379.835,381.94,385.795,387.277,391.06,394.844,398.699,400.876,405.329,406.512,408.642,411.906,415.091,418.874,421.001,424.856,426.039,428.201,431.464,435.248,438.66,442.44300000000004,444.585,448.147,449.33,451.445,455.598,459.453,463.308,464.79,466.272,469.385,472.57,474.722,476.204,479.987,483.77000000000004,485.97,489.753,491.60499999999996,493.737,495.888,497.962,501.147,504.93,508.343,511.385,514.57,520.355,521.837" y="131.47500000000002" svg_rhmargin="524.951" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">10. Wu Y, Zeng Y, Bao X, Xiong H, Fan X, Shen B. Application of tranexamic</text>
  <text x="319.748,322.933,326.047,327.529,331.384,333.524,336.709,340.493,344.348,346.451,350.305,351.787,353.269,356.974,359.126,362.539,366.394,368.561,371.973,375.828,377.31,381.093,384.506,388.361,392.144,394.217,395.699,399.483,402.896,405.07,406.552,410.33500000000004,412.44,416.295,418.368,419.85,425.635,428.82,430.893,434.00699999999995,436.194,438.345,442.129,444.28,447.465,448.947,451.104,454.887,456.369,460.22400000000005,462.329,465.514,467.587,469.739,473.523,475.596,479.379,483.234,484.716,487.901,490.494,492.646,495.759,496.942,499.122,502.685,504.167,507.95,511.733,515.588,517.718,521.722,525.505,528.69,532.544,536.249" y="140.49" svg_rhmargin="537.731" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">acid and diluted epinephrine in primary total hip arthroplasty. Blood Coagul</text>
  <text x="319.748,323.012,324.494,328.348,330.422,331.904,335.687,339.47,340.952,344.066,346.659,348.141,350.735,351.918,354.047,357.46,360.873,364.286,367.698,368.881,372.294,375.707,377.559,380.972,382.825,384.007,387.42,390.833" y="149.447" svg_rhmargin="394.246" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Fibrinolysis. 2018;29(5):451</text>
  <text x="394.243" y="149.447" svg_rhmargin="397.805" style="fill:#131413;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="397.815,401.227" y="149.447" svg_rhmargin="402.41" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">7.</text>
  <text x="304.725,308.138,311.551,312.734,319.748,323.012,326.425,330.208,334.06300000000005,336.189,339.752,340.935,343.049,348.535,351.72,353.878,356.321,357.504,359.66,365.146,368.331,370.489,374.343,375.526,377.632,383.417,386.602,390.386,394.24100000000004,396.397,399.959,401.142,403.313,406.498,410.203,412.327,415.89,417.073,419.244,423.618,427.323,431.106,433.247,437.251,438.43399999999997,440.56,443.823,447.606,451.019,453.145,456.558,458.411,460.263,461.745,464.859,468.043,471.157,474.27099999999996,476.446,479.631,483.414,487.269,489.428,492.022,495.207,497.059,500.472,502.624,505.738,507.853,511.637" y="158.461" svg_rhmargin="513.489" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">11. Teng Y, Ma J, Ma X, Wang Y, Lu B, Guo C. The efficacy and safety of</text>
  <text x="319.748,323.161,327.016,328.498,332.281,335.694,339.549,343.332,345.405,346.887,350.671,354.084,356.201,358.053,361.837,363.90999999999997,366.065,369.92,373.703,376.297,378.448,382.232,386.086,389.499,391.573,394.757,396.909,398.391,401.576,404.98900000000003,407.167,411.021,412.503,415.916,419.329,423.184,424.666,428.449,432.30400000000003,434.435,435.917,439.7,441.862,444.014,447.797,449.949,453.134,454.61600000000004,456.716,458.198,461.981,463.463,467.246,469.39799999999997,471.569,474.754,476.827,478.979,482.762,484.835,488.619,492.473,493.955,497.14,499.734,501.885,504.999,506.182,508.362,511.547,513.691,517.254,520.816,522.298,525.561,531.047,535.201" y="167.47500000000002" svg_rhmargin="537.274" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">epinephrine for postoperative bleeding in total joint arthroplasty: a PRISMA-</text>
  <text x="319.748,322.862,326.645,332.431,336.285,337.767,339.249,342.434,346.217,348.36899999999997,350.475,356.261,359.674,361.825,365.01,367.083,370.268,374.052,377.237,378.718,381.832,384.426,385.908,388.501,389.68399999999997,391.86,397.347,400.759,404.614,406.096,409.21,410.691,414.475,417.888,419.07099999999997,421.226,424.639,428.052,431.465,434.878,436.061,439.473,442.886,444.739,448.152,451.564,453.417,454.6,458.012,461.425,464.838,468.251,471.664" y="176.48900000000003" svg_rhmargin="472.847" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">compliant meta-analysis. Medicine. 2017;96(17):e6763.</text>
  <text x="304.725,308.138,311.551,312.734,319.748,323.012,326.717,328.199,329.681,332.865,336.05,339.235,341.308,345.163,348.946,352.131,355.915,359.1,361.247,364.51,365.693,367.823,371.977,374.941,377.014,380.199,383.982,387.687,389.761,392.945,395.909,398.873,402.578,404.06,406.26,409.822,411.005,413.12,417.573,421.356,425.211,428.175,429.657,431.808,435.663,439.446,442.631,444.113,447.968,451.751,455.534,459.317,461.478,467.263,468.44599999999997,470.606,473.869,477.652,481.435,485.29,487.442,488.924,491.517,495.3,497.477,502.073,503.256,505.357,508.621,510.473,512.325,513.807,516.921,520.106,523.219,526.3330000000001,528.488,532.271" y="185.44600000000003" svg_rhmargin="534.123" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">12. Tullavardhana T, Akranurakkul P, Ungkitphaiboon W, Songtish D. Efficacy of</text>
  <text x="319.748,322.342,326.047,329.901,335.687,339.392,342.505,346.289,348.882,352.067,353.54900000000004,355.691,359.104,362.958,364.44,368.224,371.636,375.491,379.274,381.348,382.83,386.613,390.026,392.2,393.682,397.466,398.948,402.36,405.474,407.626,409.108,412.891,416.67400000000004,418.789,420.641,424.425,426.498,428.653,430.805,434.588,438.00100000000003,440.105,443.96,446.033,449.446,452.631,456.044,459.827,461.979,463.461,467.244,471.02700000000004,473.213,476.997,478.849,480.98,484.835,488.618,491.212,493.363,497.218,501.001,502.483,505.597,509.451,512.864,515.978,518.129,521.913,527.698" y="194.46000000000004" svg_rhmargin="530.812" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">submucosal epinephrine injection for the prevention of postpolypectomy</text>
  <text x="319.748,323.603,325.085,328.498,331.911,335.765,337.247,341.031,344.885,346.068,348.207,351.392,353.537,359.322,362.735,364.887,368.072,370.145,373.33,377.113,380.298,381.78,384.894,387.487,388.969,391.562,393.731,397.515,399.36699999999996,401.498,403.572,406.756,410.54,414.394,418.178,423.963,425.445,428.259,431.672,435.52700000000004,437.668,440.781,444.565,448.348,450.5,452.573,456.357,457.838,459.32,462.733,466.588,468.735,471.328,473.48,477.185,481.039,482.521,485.934,488.528,489.711,491.865,496.019,499.802,503.585,506.77,508.252,510.845,513.011,516.794" y="203.47500000000002" svg_rhmargin="518.646" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">bleeding: a meta-analysis of randomized controlled studies. Annals of</text>
  <text x="319.748,325.235,328.647,332.502,333.984,337.098,338.58,342.363,345.776,347.924,351.109,354.892,358.747,360.85,364.113,367.818,369.891,373.746,377.159,379.232,382.346,383.529,385.681,389.094,392.507,395.919,399.332,400.515,403.928,407.341,410.754,414.166,416.019,419.432,422.845,424.697,425.88,429.293" y="212.48900000000003" svg_rhmargin="432.706" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Medicine and Surgery. 2012;2017(19):65</text>
  <text x="432.738" y="212.48900000000003" svg_rhmargin="436.3" style="fill:#131413;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="436.31,439.723,443.135" y="212.48900000000003" svg_rhmargin="444.318" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">73.</text>
  <text x="304.725,308.138,311.551,312.734,319.748,323.233,326.835,330.618,334.262,335.744,339.364,342.478,346.261,347.982,351.466,352.649,354.445,358.007,361.588,365.371,369.154,370.885,375.338,376.521,378.255,381.818,385.455,389.197,391.349,393.222,396.784,402.066,403.24899999999997,405.071,408.633,410.57,413.858,415.71,418.96,421.033,422.928,426.341,430.196,431.943,434.016,437.272,441.014,444.798,446.684,448.835,450.142,453.925,457.78000000000003,459.553,460.914,463.066,466.3,472.085,474.678,476.448,478.3,481.891,483.964,485.802,488.396,491.358,493.952,495.894,499.307,504.908,508.093,510.068,511.55,514.664,516.417,518.491,521.747,524.932,526.225,529.638,534.616" y="221.447" svg_rhmargin="537.209" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">13. Knobloch K, Yoon U, Vogt PM. Preferred reporting items for systematic reviews</text>
  <text x="319.748,322.81,326.593,330.44800000000004,332.221,337.891,341.303,343.276,346.461,348.379,351.563,355.181,358.243,359.725,362.665,365.258,368.504,371.09700000000004,372.926,374.778,378.198,381.761,383.074,386.337,391.635,395.659,397.51099999999997,399.401,401.995,403.937,407.122,409.096,412.509,418.111,421.524,425.141,427.293,429.11,432.294,435.912,439.767,441.582,445.436,449.008,452.75,454.232,455.528,458.642,461.65,463.802,465.109,468.892,472.675,474.463,478.205,479.687,482.684,485.277,486.46,488.24,490.684,492.492,496.496,498.388,501.573,505.191,506.673,510.293,516.078,519.08,522.122,523.445,524.806,526.288,529.909,531.761,534.784" y="230.461" svg_rhmargin="537.898" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">and meta-analyses (PRISMA) statement and publication bias. J Craniomaxillofac</text>
  <text x="319.748,323.012,326.495,328.568,332.278,333.461,335.282,338.695,341.915,345.328,348.605,349.788,353.027,356.315,358.167,361.417,363.27,364.251,367.664" y="239.47500000000002" svg_rhmargin="371.077" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Surg. 2011;39(2):91</text>
  <text x="370.942" y="239.47500000000002" svg_rhmargin="374.504" style="fill:#131413;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="374.401,377.689" y="239.47500000000002" svg_rhmargin="378.872" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">2.</text>
  <text x="304.725,308.138,311.551,312.734,319.749,324.123,327.308,331.091,333.241,336.504,337.687,339.817,343.08,346.785,350.56800000000004,352.686,358.472,359.655,361.814,366.189,369.894,373.677,375.817,381.603,382.786,384.945,388.13,389.612,391.748,395.531,396.714,398.834,404.62,407.805,411.588,415.44300000000004,417.599,423.385,424.568,426.727,430.731,434.514,437.927,441.711,445.56600000000003,447.703,450.887,452.07,454.222,457.485,461.268,465.123,466.605,469.719,472.903,474.38500000000005,476.502,479.686,483.541,487.396,488.878,490.359,493.473,496.658,498.81,500.292,504.075,507.858,510.063,513.846" y="248.48900000000003" svg_rhmargin="515.698" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">14. Gao F, Sun W, Guo W, Li Z, Wang W, Cheng L. Topical application of</text>
  <text x="319.748,321.9,323.974,327.158,330.942,334.355,337.397,340.582,346.367,347.849,350.96299999999997,353.083,356.268,359.382,360.863,364.718,366.859,370.714,372.196,375.901,378.494,380.635,384.49,385.972,387.454,391.159,393.31,396.723,400.57800000000003,402.745,406.158,410.013,411.494,415.278,418.691,422.545,426.329,428.402,429.884,433.667,437.08,439.255,441.328,444.741,448.595,452.3,455.414,458.827,461.42,463.575,467.43,471.213,473.807,475.959,479.742,483.596,487.009,489.083,492.267,494.419,495.901,499.086,502.499,504.621,508.404,509.886,513.741,517.595,521.008" y="257.447" svg_rhmargin="524.791" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">tranexamic acid plus diluted epinephrine reduces postoperative hidden</text>
  <text x="319.748,323.603,325.085,328.868,332.652,336.507,338.627,340.109,343.892,346.485,349.07800000000003,351.212,352.694,356.47700000000003,358.639,360.791,364.574,366.726,369.911,371.39300000000003,373.549,377.333,378.815,382.67,384.775,387.959,390.033,392.185,395.968,398.041,401.825,405.679,407.161,410.346,412.939,415.091,418.205,419.388,421.568,424.012,426.16,430.313,432.387,434.539,438.322,440.395,444.179,448.033,449.515,452.7,455.293,457.445,458.628,460.798,464.211,467.624,471.037,474.449,475.632,479.045,482.458,484.31,487.723,491.136,492.989,494.171,497.584,500.997,504.41" y="266.461" svg_rhmargin="507.823" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">blood loss in total hip arthroplasty. J Arthroplast. 2015;30(12):2196</text>
  <text x="507.799" y="266.461" svg_rhmargin="511.361" style="fill:#131413;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="511.371,514.784,518.197,521.61" y="266.461" svg_rhmargin="522.793" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">200.</text>
  <text x="304.725,308.138,311.551,312.734,319.748,322.073,325.257,328.876,331.469,333.297,338.042,339.22499999999997,341.007,345.259,347.333,350.589,353.774,356.201,358.353,361.36,365.21500000000003,367.029,371.483,372.666,374.399,379.886,382.903,386.686,390.386,394.17,397.583,399.344,403.797,404.98,406.714,410.198,413.403,417.187,418.505,421.918,424.07,425.818,430.272,431.455,433.188,435.632,439.255,443.038,446.058,449.841,452.237,454.83,458.416,462.199,464.086,467.648,468.904,470.087,471.966,476.12,477.919,479.992,483.021,486.804,490.504,494.287,499.858,501.34,503.997,507.41,511.26500000000004,513.011,515.163,517.036,518.518,521.572,523.054,524.86,528.643" y="275.475" svg_rhmargin="530.495" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">15. Jans O, Grevstad U, Mandoe H, Kehlet H, Johansson PI. A randomized trial of</text>
  <text x="319.748,321.9,325.474,328.887,330.746,334.035,335.887,337.549,340.962,343.899,346.051,347.924,351.707,353.55899999999997,355.294,356.776,360.396,365.512,367.313,371.168,374.796,377.39,380.803,382.563,385.851,389.706,391.01,394.794,398.041,401.895,405.524,407.597,408.869,412.652,416.065,417.826,419.308,422.929,424.781,428.314,430.908,432.17,435.953,439.736,441.524,442.885,446.668,448.497,451.682,455.357,459.211,460.572,462.724,463.974,467.757,471.54,473.328,475.48,479.26300000000003,480.982,483.133,485.063,488.125,491.908,495.155,498.197,501.221,506.891,508.373,511.48699999999997,513.24,516.425,519.363,520.845,524.7,526.449,530.232" y="284.48900000000003" svg_rhmargin="534.015" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">the effect of low dose epinephrine infusion in addition to tranexamic acid on</text>
  <text x="319.748,323.49,324.972,328.593,332.376,336.231,337.947,339.429,343.049,345.643,348.236,349.965,353.82,357.392,359.465,360.737,364.52,368.375,370.148,372.3,375.874,378.025,381.033,382.51500000000004,384.378,388.161,389.48,393.33500000000004,395.149,398.334,400.251,402.403,405.978,408.051,411.647,415.502,416.806,419.991,422.418,424.57,427.521,428.704,430.525,434.088,436.161,437.952,440.396,442.204,446.358,449.971,453.156,456.377,458.971,460.969,464.752,465.935,467.659,471.072,474.292,477.705,480.982,482.164,485.403,488.691,492.104,493.794,497.207,498.896,500.079,503.318,506.606" y="293.447" svg_rhmargin="510.019" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">blood loss during total hip arthroplasty. Br J Anaesth. 2016;116(3):357</text>
  <text x="509.953" y="293.447" svg_rhmargin="513.515" style="fill:#131413;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="513.412,516.825,520.045" y="293.447" svg_rhmargin="521.228" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">62.</text>
  <text x="304.725,308.138,311.551,312.734,319.748,322.933,324.415,328.12,330.236,332.68,335.865,337.048,339.194,342.977,346.39,350.173,354.028,356.202,361.987,366.511,367.694,369.807,375.593,378.778,382.561,386.416,388.572,391.836,395.398,396.581,398.72,402.724,406.508,409.921,413.704,415.841,419.846,421.029,423.154,427.529,431.312,435.096,438.951,441.126,444.98,448.543,449.726,451.84,455.402,458.587,462.371,466.226,468.394,472.847,474.03,476.161,479.424,482.609,486.392,488.52,492.303,494.747,495.93,498.101,500.545,502.027,505.212,507.342,511.196,514.381,515.564,517.716,521.279,524.464,528.247" y="302.461" svg_rhmargin="532.102" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">16. Liu JL, Zeng WN, Wang FY, Chen C, Gong XY, Yang H, Tan ZJ, Jia XL, Yang</text>
  <text x="319.748,322.933,324.116,326.211,329.475,331.327,333.18,336.592,339.706,341.858,344.451,346.621,350.404,352.256,354.388,355.87,359.653,364.769,366.842,370.697,374.48,377.073,380.486,382.677,386.09,389.945,391.426,395.21,398.623,402.477,406.261,408.334,409.816,413.599,417.012,419.13,422.913,426.696,428.824,432.678,436.091,438.164,439.646,443.43,447.284,450.697,452.771,455.955,458.107,459.589,462.774,466.187,468.395,472.178,475.591,481.376,485.16,487.753,489.905,493.09,495.683,497.165,499.75800000000004,501.9,505.085,508.868" y="311.475" svg_rhmargin="512.723" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">L. Effects of low-dose epinephrine on perioperative hemostasis and</text>
  <text x="319.748,321.23,325.014,326.866,328.348,331.533,337.318,343.104,346.289,348.44,352.224,354.297,357.411,359.546,361.619,365.032,368.217,371.331,373.482,374.964,378.748,382.531,384.661,386.143,389.926,392.088,397.873,401.058,402.54,406.323,408.39599999999996,410.569,413.162,416.867,418.941,422.795,424.277,427.391,430.576,432.05800000000005,434.209,437.993,441.847,445.26,447.333,450.518,452.67,454.152,457.935,461.719,464.312,465.495,467.657,470.842,472.987,475.06,478.245,482.028,485.883,489.666,495.452,496.934,499.748,503.161,507.016,509.156,512.27,513.752,515.234,519.017,520.499,523.613,526.798" y="320.489" svg_rhmargin="528.28" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">inflammatory reaction in major surgical operations: a randomized clinical</text>
  <text x="319.748,321.9,323.974,325.455,328.64,330.122,331.305,333.411,335.855,337.038,339.194,342.457,346.24,348.314,352.097,357.882,361.737,362.92,365.102,369.555,372.74,376.153,381.938,385.722,388.315,390.467,391.65,393.788,397.201,400.614,404.027,407.44,408.622,412.035,415.448,417.301,420.713,422.566,423.749,427.162" y="329.447" svg_rhmargin="430.575" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">trial. J. Thromb. Haemost. 2018;16(1):74</text>
  <text x="430.583" y="329.447" svg_rhmargin="434.145" style="fill:#131413;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="434.155,437.568,440.981" y="329.447" svg_rhmargin="442.164" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">82.</text>
  <text x="304.725,308.138,311.551,312.734,319.748,325.418,328.603,332.221,336.076,337.89,340.334,345.94,347.123,349.002,352.564,355.749,359.53200000000004,361.418,364.681,368.901,370.084,371.963,375.226,378.823,382.236,384.038,387.451,389.14,390.993,394.242,397.356,399.345,401.93800000000005,403.767,407.55,409.402,411.137,413.289,416.863,420.718,422.022,425.136,428.202,429.684,431.49,433.642,435.515,438.7,442.318,445.731,448.61,451.795,457.398,458.88,461.99399999999997,463.747,466.932,469.87,471.352,475.207,476.956,480.698,482.18,485.744,488.33700000000005,490.166,493.579,497.253,498.735,502.355,505.643,509.498,513.126,515.2,516.528,520.311,523.724,525.428,527.281,530.927" y="338.461" svg_rhmargin="533.0" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">17. Wang JW, Ren SH. The effects of topical tranexamic acid plus epinephrine for</text>
  <text x="319.748,323.49,324.972,328.593,332.376,336.231,337.947,339.429,343.049,345.643,348.236,349.965,351.447,355.23,356.995,359.147,362.778,364.93,367.937,369.41900000000004,371.225,375.009,376.327,380.182,381.997,385.181,387.099,389.251,392.825,394.898,398.551,402.293,403.775,406.772,409.366,411.364,414.47799999999995,416.297,420.151,423.157,425.308,426.615,430.028,433.645,435.797,438.237,439.42,441.242,443.68600000000004,445.494,449.056,450.993,454.054,457.168,459.32,461.085,466.571,469.815,473.557,474.74,476.619,479.907,483.32,486.54,489.953,490.962,494.375,497.652,499.504,502.698,504.55,505.589,508.877,512.29" y="347.475" svg_rhmargin="515.703" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">blood loss in total hip arthroplasty patients. J Pract Med. 2017;33(2):279</text>
  <text x="515.566" y="347.475" svg_rhmargin="519.128" style="fill:#131413;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="519.025,522.313,525.726" y="347.475" svg_rhmargin="526.909" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">81.</text>
  <text x="304.725,308.138,311.551,312.734,319.748,323.532,327.315,330.5,334.283,338.13800000000003,340.271,342.715,346.199,347.382,349.512,352.697,354.179,357.364,361.147,365.002,367.143,370.706,374.56,375.743,377.915,381.1,382.582,386.287,388.403,392.186,393.36899999999997,395.546,398.809,400.662,402.514,405.927,409.041,411.192,413.785,415.898,419.682,421.534,423.722,425.874,429.657,433.512,434.994,438.107,441.292,442.774,444.925,448.11,451.965,455.819,457.301,458.783,461.897,465.082,467.233,468.715,472.499,476.28200000000004,478.43,482.214,484.066,486.197,488.349,490.422,493.607,497.39,500.803,503.845,507.03,512.816,514.298,517.412,519.589,522.773,525.887,527.369" y="356.489" svg_rhmargin="531.224" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">18. Zhang JK, Liang PX, Liu Z. Effects of topical application of tranexamic acid</text>
  <text x="319.748,323.603,325.085,328.79,331.38300000000004,333.524,336.709,340.564,342.637,346.05,349.833,353.018,354.5,355.982,359.765,363.178,365.329,366.811,370.594,372.699,374.85,378.634,380.785,383.97,385.45200000000006,387.609,391.392,392.874,396.72900000000004,398.89,402.075,404.149,406.3,410.084,412.157,415.94,419.795,421.277,424.462,427.055,429.207,432.321,433.504,435.684,438.127,441.911,445.616,447.689,451.472,454.657,456.139,458.304,462.087,463.93899999999996,466.07,470.075,471.557,473.039,476.822,478.304,481.417,484.602,486.084,488.237,492.982,495.055,497.207,500.99,504.774,508.628,511.813,515.226,519.08,520.562,523.676,526.269" y="365.446" svg_rhmargin="527.452" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">plus adrenaline in total hip arthroplasty. Journal of Clinical Orthopaedics.</text>
  <text x="319.748,323.161,326.574,329.987,333.4,334.583,337.995,341.408,343.261,346.674,348.526,349.709,353.122" y="374.46" svg_rhmargin="356.535" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">2017;20(1):58</text>
  <text x="356.542" y="374.46" svg_rhmargin="360.104" style="fill:#131413;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="360.057,363.47,366.883" y="374.46" svg_rhmargin="368.066" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">61.</text>
  <text x="304.724,308.137,311.55,312.733,319.748,323.531,327.314,330.499,334.283,338.13800000000003,340.27,342.714,346.498,347.681,349.795,353.578,357.362,361.067,363.231,366.715,367.89799999999997,370.034,374.487,377.9,383.685,387.469,390.062,392.214,395.399,397.992,399.474,402.067,404.219,407.632,409.485,411.337,414.75,417.864,420.01599999999996,422.191,425.974,427.82599999999996,429.957,431.439,435.223,438.336,441.521,443.00300000000004,445.151,448.335,452.19,456.045,457.526,459.008,462.122,465.307,467.459,468.941,472.724,476.507,478.655,482.439,484.291,486.422,488.574,490.647,493.832,497.615,501.028,504.071,507.255,513.041,514.523,517.6370000000001,519.814,522.999,526.112,527.594" y="383.474" svg_rhmargin="531.449" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">19. Zhang JZ, Zhu K. Hemostasis effect of local application of tranexamic acid</text>
  <text x="319.748,322.933,326.716,330.571,332.674,336.087,339.941,341.423,345.206,348.619,352.474,356.257,358.331,359.813,363.596,367.009,369.183,371.036,374.819,376.892,379.048,381.199,384.983,387.134,390.319,391.80100000000004,393.901,397.684,399.166,403.021,405.182,408.367,410.441,412.592,416.376,418.449,422.232,426.087,427.569,430.754,433.347,435.499,438.613,439.796,441.976,444.419,448.203,451.908,453.981,457.764,460.949,462.43100000000004,464.596,468.379,470.231,472.363,476.367,477.849,479.331,483.114,484.596,487.71,490.894,492.37600000000003,494.529,499.274,501.347,503.499,507.282,511.066,514.92,518.105,521.518,525.372,526.854,529.968,532.561" y="392.488" svg_rhmargin="533.744" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">and epinephrine for total hip arthroplasty. Journal of Clinical Orthopaedics.</text>
  <text x="319.748,323.161,326.573,329.986,333.399,334.582,337.995,341.408,343.26,346.673,348.525,349.708,353.121,356.534" y="401.446" svg_rhmargin="359.947" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">2017;20(3):318</text>
  <text x="359.943" y="401.446" svg_rhmargin="363.505" style="fill:#131413;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="363.515,366.927,370.34" y="401.446" svg_rhmargin="371.523" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">21.</text>
  <text x="304.724,308.137,311.55,312.733,319.748,323.31,327.015,329.158,332.942,334.125,336.245,339.807,342.992,346.77500000000003,348.887,352.072,353.255,355.406,358.969,362.154,365.937,369.79200000000003,371.961,376.706,377.889,380.011,383.274,385.347,388.532,392.316,395.728,398.771,401.956,407.741,409.223,412.337,414.536,417.721,420.835,422.316,426.171,428.312,432.167,433.649,437.354,439.947,442.088,445.943,447.425,448.907,452.612,454.763,458.176,462.031,464.104,467.517,471.371,472.853,476.637,480.05,483.904,487.688,489.761,491.243,495.026,498.439,500.594,503.778,507.191,509.265,511.858,515.563" y="410.46" svg_rhmargin="518.156" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">20. Yu Z, Yao L, Yang Q. Tranexamic acid plus diluted-epinephrine versus</text>
  <text x="319.748,321.899,323.973,327.158,330.941,334.354,337.396,340.581,346.366,347.848,350.962,353.082,356.267,359.381,360.863,364.718,366.858,370.043,371.525,375.308,379.092,382.505,384.66,386.512,390.296,392.36899999999997,394.524,398.379,399.861,403.644,407.428,411.283,413.402,414.884,418.668,421.261,423.85400000000004,426.045,427.527,431.31,433.415,435.567,439.35,441.502,444.687,446.16900000000004,448.324,449.806,453.59,455.072,458.855,461.007,463.121,466.306,468.379,470.531,474.314,476.387,480.171,484.025,485.507,488.692,491.286,493.437,496.551,497.734,499.914,503.099,505.243,511.029,514.441,516.593,519.778" y="419.474" svg_rhmargin="521.851" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">tranexamic acid alone for blood loss in total joint arthroplasty: a meta-</text>
  <text x="319.748,322.933,326.716,329.901,331.383,334.496,337.09,338.572,341.165,342.348,344.465,349.952,353.365,357.219,358.701,361.815,363.297,367.08,370.493,371.676,373.832,377.244,380.657,384.07,387.483,388.666,392.078,395.491,397.344,400.757,404.169,406.022,407.205,410.618,414.03,417.443,420.856,424.269" y="428.488" svg_rhmargin="425.452" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">analysis. Medicine. 2017;96(24):e7095.</text>
  <text x="304.724,308.137,311.55,312.733,319.748,323.773,325.133,327.571,331.354,333.24,336.188,339.93,343.115,344.976,348.094,349.277,351.099,354.217,357.922,360.68,363.968,365.329,368.293,370.091,375.577,376.76,378.481,381.599,384.661,386.734,390.386,393.571,395.375,398.777,399.96,401.781,405.344,406.6,409.888,413.671,416.407,417.768,421.397,423.99,427.576,431.318,435.173,436.987,439.312,440.495,442.26,446.713,449.687,453.429,457.171,460.232,464.08700000000005,465.902,469.02,472.283,473.466,475.199,480.528,483.59,486.184,489.769,493.552,495.325,497.65,503.136,504.319,506.04" y="437.445" svg_rhmargin="510.194" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">21. Alshryda S, Sukeik M, Sarda P, Blenkinsopp J, Haddad FS, Mason JM. A</text>
  <text x="319.748,322.186,325.299,327.685,329.837,333.014,338.684,341.745,343.897,345.147,348.26099999999997,350.022,352.096,355.295,358.356,359.717,363.005,368.121,369.922,373.107,376.669,380.524,382.338,388.007,391.295,393.447,396.398,398.471,401.443,405.072,408.257,409.551,412.664,414.994,416.354,418.947,420.776,424.559,426.411,428.089,430.241,433.758,437.171,439.031,441.015,444.799,448.442,449.803,452.917,455.869,457.35100000000006,459.157,462.219,465.961,471.63,472.991,476.774,478.037,480.474,482.626,484.499,487.561,489.712,490.962,494.59,498.373,500.202,503.986,505.83799999999997,507.515,509.667,511.484,514.669,518.231,521.519,524.561,527.528,533.197,534.558" y="446.459" svg_rhmargin="537.672" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">systematic review and meta-analysis of the topical administration of tranexamic</text>
  <text x="319.748,322.809,325.922,327.174,331.029,332.843,334.201,337.98400000000004,339.757,341.909,345.484,347.468,350.653,352.13500000000005,353.874,357.503,358.861,362.716,364.53,367.591,371.374,375.22900000000004,376.945,379.779,383.563,386.752,390.165,391.968,393.895,397.184,400.915,402.273,405.333,408.447,411.626,417.288,420.576,424.36,426.302,427.485,429.306,432.708,436.491,440.078,443.491,445.293,447.617,451.277,452.635,456.418,458.57,460.288,462.608,463.791,465.613,468.902,472.19,475.479,478.768,479.951,483.134,486.422,488.371,492.102,493.954,497.148,499.0,499.926,503.214,506.627,509.848" y="455.473" svg_rhmargin="513.261" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">acid in total hip and knee replacement. Bone Joint J. 2014;96-b(8):1005</text>
  <text x="513.128" y="455.473" svg_rhmargin="516.69" style="fill:#131413;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="516.529,519.817,523.23" y="455.473" svg_rhmargin="524.413" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">15.</text>
  <text x="304.723,308.136,311.549,312.73199999999997,319.747,325.303,328.534,330.016,331.766,335.338,336.521,338.286,341.291,342.592,346.29699999999997,348.034,353.339,354.522,356.288,359.37,362.972,366.385,368.131,371.363,373.035,374.706,377.881,380.829,382.8,384.048,387.052,390.283,393.886,397.061,399.473,402.06600000000003,403.782,406.785,410.388,414.243,415.944,418.382,421.386,423.057,426.289,428.216,431.33,433.092,436.664,438.51599999999996,440.292,442.22,444.112,447.116,450.718,453.95,456.811,459.815,465.42,466.667,469.78099999999995,471.543,474.547,477.439,478.742,482.59700000000004,484.355,485.659,489.442,491.158,493.142,496.744,498.715,501.719,503.201,504.894,508.496,509.797,513.652,515.353,518.982,521.055,522.78,525.558,529.16,532.392" y="464.488" svg_rhmargin="535.805" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">22. Wei Z, Liu M. The effectiveness and safety of tranexamic acid in total hip or knee</text>
  <text x="319.747,322.749,324.639,326.566,330.195,332.085,335.685,339.357,340.656,343.657,346.068,348.036,350.967,352.15,353.858,357.043,358.791,364.393,367.568,369.536,372.538,374.428,377.43,381.03,384.032,385.28,388.228,390.638,391.937,394.53000000000003,396.302,399.874,401.726,403.446,406.677,409.907,413.136,416.54900000000004,418.279,421.171,424.175,426.589,429.764,432.178,433.361,435.069,438.153,440.047,443.052,446.656,449.07,450.742,454.268,456.861,458.633,463.94,467.173,470.848,472.031,473.74,476.973,480.206,483.439,486.614,487.617,490.851,494.084,495.757,498.99,500.663,501.666,504.899,508.133" y="473.445" svg_rhmargin="511.546" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">arthroplasty: a meta-analysis of 2720 cases. Transfus Med. 2015;25(3):151</text>
  <text x="511.256" y="473.445" svg_rhmargin="514.818" style="fill:#131413;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="514.657,517.888,521.12" y="473.445" svg_rhmargin="522.303" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">62.</text>
  <text x="304.723,308.136,311.548,312.731,319.746,323.9,327.755,331.609,335.022,336.504,338.624,344.111,347.673,348.856,350.983,354.988,358.771,361.956,363.438,369.223,372.636,374.709,377.302,379.499,383.062,386.624,387.807,389.931,393.194,396.379,400.084,403.867,406.019,409.802,413.58500000000004,415.726,421.212,423.656,424.839,427.008,430.57,433.755,437.609,441.393,444.578,448.361,452.144,454.276,459.762,465.548,466.731,468.903,472.166,474.239,478.023,481.728,484.321,488.176,491.36,492.842,496.255,498.383,501.945,505.208,506.391,508.531,511.794,513.276,516.689,518.762,520.836,524.021,526.162,529.724,532.168" y="482.459" svg_rhmargin="533.351" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">23. Abdel MP, Chalmers BP, Taunton MJ, Pagnano MW, Trousdale RT, Sierra RJ,</text>
  <text x="319.746,322.931,326.344,329.757,331.879,335.441,339.004,340.187,342.31,345.873,349.656,353.069,355.221,357.372,361.156,364.568,366.64099999999996,368.785,372.048,373.231,375.361,378.624,382.329,384.489,387.752,391.315,392.498,394.637,399.09,402.275,405.46,408.053,410.227,413.49,417.053,418.236,420.375,423.788,425.94,428.085,431.27,432.752,433.935,436.078,437.56,441.344,443.495,445.569,448.753,451.938,455.351,459.134,462.918,466.623,469.216,471.34,474.525,477.938,480.011,482.605,486.31,488.903,491.069,493.221,497.004,500.859,502.341,505.454,508.639" y="491.473" svg_rhmargin="510.121" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Lee YY, Boettner F, Su EP, Haas SB, et al. Intravenous versus topical</text>
  <text x="319.746,321.898,323.971,327.156,330.94,334.352,337.395,340.58,346.365,347.847,350.96099999999996,353.081,356.266,359.379,360.861,364.716,366.857,368.339,372.122,374.284,376.436,380.219,382.371,385.556,387.038,389.194,392.158,395.941,399.354,402.767,404.898,408.083,410.156,412.308,416.091,418.165,421.948,425.803,427.285,430.469,433.063,435.215,438.328,439.51099999999997,441.691,445.546,449.329,451.481,455.264,457.395,460.808,462.661,464.513,467.926,471.039,473.191,474.673,477.858,481.271,483.417,484.899,488.682,490.844,494.029,496.173,498.247,501.431,505.215,509.069,512.853,518.638,520.12,522.934,526.347" y="500.487" svg_rhmargin="530.202" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">tranexamic acid in total knee arthroplasty: both effective in a randomized</text>
  <text x="319.746,322.86,324.342,325.824,329.607,331.089,334.203,337.388,338.87,341.006,343.157,345.231,346.713,349.897,351.379,353.535,357.318,359.16999999999996,361.302,364.714,368.127,371.54,373.66,377.515,380.7,382.852,384.334,387.746,391.53,393.681,396.275,397.45799999999997,399.625,402.069,404.217,407.779,411.563,415.346,418.759,420.884,423.328,427.112,428.593,432.377,434.529,436.702,439.965,443.67,445.743,449.598,451.725,455.879,461.664,462.847,464.991,468.404,471.817,475.23,478.642,479.825,483.238,486.651,490.064,491.916,495.329,498.742,500.594,501.777,505.19,508.603,512.016" y="509.444" svg_rhmargin="515.429" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">clinical trial of 640 patients. J Bone Joint Surg Am. 2018;100(12):1023</text>
  <text x="515.451" y="509.444" svg_rhmargin="519.013" style="fill:#131413;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="519.023,522.435" y="509.444" svg_rhmargin="523.618" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">9.</text>
  <text x="304.723,308.136,311.548,312.731,319.746,325.532,328.945,330.427,332.559,338.344,339.527,341.63,346.225,349.41,353.194,357.04900000000004,359.204,362.467,363.65,365.837,370.433,374.138,377.323,381.106,383.242,387.838,389.021,391.179,396.965,400.378,401.86,403.991,407.176,408.359,410.511,414.515,418.298,424.084,427.938,431.123,433.196,434.678,437.272,441.055,444.838,446.963,450.746,452.59799999999996,454.73,456.212,459.995,462.147,464.22,467.405,470.59,474.003,477.786,481.569,485.274,487.867,490.049,493.234,497.017,500.872,503.031,505.183,508.966,512.821,514.303,517.416,520.601" y="518.4580000000001" svg_rhmargin="522.083" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">24. Wei W, Dang S, Duan D, Wei L. Comparison of intravenous and topical</text>
  <text x="319.746,321.898,323.971,327.156,330.94,334.352,337.395,340.58,346.365,347.847,350.96099999999996,353.081,356.266,359.379,360.861,364.716,366.857,368.339,372.122,374.284,376.436,380.219,382.371,385.556,387.038,389.194,392.158,395.941,399.354,402.767,404.898,408.083,410.156,412.308,416.091,418.165,421.948,425.803,427.285,430.469,433.063,435.215,438.328,439.51099999999997,441.691,445.254,450.74,454.744,456.884,462.371,466.075,468.669,471.783,475.487,476.969,480.753,483.346,486.31,489.723,491.205,494.618,496.77,498.893,503.488,504.97,507.564,511.347,513.42,517.275,518.458,520.662,524.075,527.488,530.901,534.314" y="527.472" svg_rhmargin="535.497" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">tranexamic acid in total knee arthroplasty. BMC Musculoskelet Disord. 2018;</text>
  <text x="319.746,323.159,326.572,328.424,331.837,333.69,334.873,338.285,341.698,345.111" y="536.4870000000001" svg_rhmargin="346.294" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">19(1):191.</text>
  <text x="304.723,308.136,311.548,312.731,319.746,322.808,326.513,330.296,332.049,335.832,339.249,340.432,342.253,347.922,351.107,354.725,358.58000000000004,360.452,364.93,366.113,367.935,373.421,376.666,380.449,384.30400000000003,386.077,391.746,395.23,396.413,398.152,403.938,406.997,410.78,414.635,416.351,420.804,424.175,425.358,427.236,430.799,433.756,437.539,439.425,443.733,444.916,446.795,450.357,453.598,455.08000000000004,456.886,460.149,463.859,465.042,466.864,470.647,474.234,478.017,481.722,483.475,487.258,490.561,491.74399999999997,493.566,498.311,500.255,503.317,504.79900000000004,506.662,508.814,510.687,513.872,517.49,520.902,523.782,526.844,532.629,533.93" y="545.444" svg_rhmargin="537.044" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">25. Luo ZY, Wang D, Meng WK, Wang HY, Pan H, Pei FX, Zhou ZK. Oral tranexamic</text>
  <text x="319.746,322.931,326.209,327.797,331.65200000000004,333.863,335.45,338.043,340.27,343.784,347.639,351.494,353.082,356.37,359.658,361.245,364.658,368.615,370.767,372.981,375.249,379.03200000000004,381.258,383.469,387.324,391.293,392.88,396.055,399.343,400.82500000000005,403.085,405.296,407.45,410.739,414.65,418.063,421.283,424.572,430.357,431.998,435.11199999999997,437.327,440.615,443.847,445.328,449.183,451.5,456.716,458.198,460.515,464.37,468.281,472.08,474.23199999999997,476.445,480.3,482.568,485.856,487.338,491.298,494.483,498.498,501.911,504.167,505.649,509.432,511.708,515.676,517.831,519.418,525.314,528.602,530.757" y="554.458" svg_rhmargin="533.871" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">acid is equivalent to topical tranexamic acid without drainage in primary</text>
  <text x="319.746,321.957,325.812,328.08,331.368,332.85,335.053,338.965,340.447,344.302,346.619,349.907,352.061,354.272,358.184,360.338,364.194,368.162,369.75,373.038,375.702,377.913,381.145,382.328,384.546,387.731,389.989,393.843,397.813,401.611,405.465,407.11,410.625,412.779,416.748,418.335,419.817,423.778,427.63300000000004,429.844,431.999,435.287,439.142,443.111,446.966,452.862,454.449,457.34,460.855,464.71000000000004,466.921,470.153,471.741,473.222,477.183,478.665,481.945,485.234,486.716,488.919,491.186,493.341,494.928,498.217,499.699,500.882,503.205,506.551,510.406,512.56,516.472,522.257" y="563.472" svg_rhmargin="526.112" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">total hip arthroplasty: a double-blind randomized clinical trial. Thromb</text>
  <text x="319.746,323.403,326.91,329.597,330.78,332.999,336.505,340.012,343.519,347.026,348.274,351.781,355.287,358.7,360.05" y="572.486" svg_rhmargin="363.463" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Res. 2018;167:1</text>
  <text x="363.57" y="572.486" svg_rhmargin="367.132" style="fill:#131413;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="367.2,370.715" y="572.491" svg_rhmargin="371.898" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">5.</text>
  <text x="304.724,308.137,311.55,312.733,319.748,322.933,326.716,330.499,332.617,336.101,339.286,343.069,346.482,347.96400000000006,350.135,353.698,354.881,356.995,361.591,363.072,368.858,371.451,375.306,378.491,379.973,383.386,385.568,388.012,391.275,392.45799999999997,394.582,397.845,399.697,401.55,404.963,408.076,410.228,412.821,414.991,418.774,420.626,422.758,425.351,428.465,434.25,438.105,441.29,443.442,447.225,450.638,452.789,454.271,457.385,459.551,462.736,465.849,468.001,469.483,472.668,475.853,478.004,479.486,483.27,487.053,489.201,493.055,496.169,498.328,501.513,505.368,507.441,510.854,514.637,518.05,520.123,523.978,525.46" y="581.4490000000001" svg_rhmargin="528.574" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">26. von Kanel R, Dimsdale JE. Effects of sympathetic activation by adrenergic</text>
  <text x="319.748,321.23,325.013,326.866,330.571,333.164,334.646,338.43,342.213,344.80600000000004,346.96,350.744,354.52700000000004,356.654,360.438,363.851,369.636,373.419,376.013,378.164,381.349,383.943,385.425,388.01800000000003,390.159,391.641,395.42400000000004,397.586,400.771,402.253,405.438,409.221,410.404,412.553,415.816,419.521,421.594,423.721,426.165,428.313,432.766,435.951,439.364,445.149,448.334,450.486,454.269,455.751,456.93399999999997,459.097,462.51,465.923,469.336,472.748,473.931,477.344,480.757,482.609,486.022,487.875,489.057,492.47,495.883" y="590.463" svg_rhmargin="499.296" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">infusions on hemostasis in vivo. Eur J Haematol. 2000;65(6):357</text>
  <text x="499.295" y="590.463" svg_rhmargin="502.857" style="fill:#131413;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="502.867,506.279,509.692" y="590.463" svg_rhmargin="510.875" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">69.</text>
  <text x="304.724,308.137,311.55,312.733,319.748,323.093,326.098,328.881,332.483,335.487,336.788,339.902,341.663,346.029,347.212,348.977,352.322,353.623,356.627,359.631,362.74499999999995,364.507,368.85,370.033,371.798,374.88,376.808,380.04,381.932,385.534,388.538,389.839,392.953,394.658,399.072,400.255,402.021,405.366,407.237,410.469,412.881,415.664,419.266,422.27,423.571,426.685,428.39,431.451,432.634,434.4,437.971,441.495,445.169,446.47,450.25300000000004,451.969,455.35,456.533,458.242,462.806,466.434,469.438,473.293,475.05,479.023,480.206,481.914,486.329,489.853,491.154,492.455,495.56899999999996,497.273,500.876,502.05899999999997,503.767,506.849,510.452,513.865,515.611,518.842,520.513,522.185,525.417,528.349,530.277" y="599.477" svg_rhmargin="532.87" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">27. Bakovic D, Pivac N, Eterovic D, Breskovic T, Zubin P, Obad A, Dujic Z. The effects</text>
  <text x="319.748,323.343,325.195,326.914,328.207,331.802,336.729,338.613,342.242,345.87,348.275,351.688,353.434,356.658,360.324,361.571,365.2,368.424,372.053,375.647,377.532,378.825,382.419,385.832,387.579,388.883,392.477,394.141,397.657,400.061,401.355,404.949,408.732,410.505,414.077,417.86,419.576,422.013,425.642,426.946,430.17,433.394,437.177,438.917,441.327,442.626,445.257,448.487,449.67,451.378,454.327,457.556,461.157,463.125,465.015,468.017,469.499,471.249,474.251,477.851,481.706,483.463,487.035,490.265,493.936,496.938,498.865,500.164,503.27799999999996,504.983,507.913,509.212,511.102,514.033,517.554,518.853,521.855,523.782,525.081,528.681" y="608.491" svg_rhmargin="532.464" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">of low-dose epinephrine infusion on spleen size, central and hepatic circulation</text>
  <text x="319.748,322.755,326.36,330.21500000000003,331.972,334.863,336.167,338.063,340.998,344.525,345.829,348.835,350.763,352.067,355.672,359.52700000000004,361.284,364.961,366.264,369.271,371.198,374.433,375.737,378.972,380.899,383.314,384.497,386.206,390.032,391.279,392.583,396.36600000000004,398.082,401.466,405.015,407.95,410.365,411.669,415.274,416.75600000000003,418.449,421.566,425.093,428.698,431.633,433.78499999999997,435.488,436.792,442.399,445.406,449.033,450.337,453.942,457.57,458.753,460.518,463.752,466.926,470.161,473.396,474.401,477.635,480.809,482.484,485.718,487.393,488.397,491.572" y="617.4490000000001" svg_rhmargin="494.985" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">and circulating platelets. Clin Physiol Funct Imaging. 2013;33(1):30</text>
  <text x="494.816" y="617.4490000000001" svg_rhmargin="498.378" style="fill:#131413;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="498.218,501.449" y="617.4490000000001" svg_rhmargin="502.632" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">7.</text>
  <text x="304.724,308.137,311.549,312.73199999999997,319.747,322.932,326.345,327.82700000000006,329.952,333.514,334.697,336.812,341.265,344.97,348.154,351.938,355.793,357.958,362.703,363.88599999999997,366.008,370.461,374.166,377.351,381.134,384.98900000000003,387.154,390.937,392.12,394.297,398.152,399.634,403.047,405.182,407.626,408.80899999999997,410.908,414.913,418.696,422.109,425.892,428.086,432.461,433.644,435.739,439.302,442.715,444.197,446.341,449.604,450.787,452.917,458.403,462.108,463.59,465.742,467.224,471.078,472.56,475.973,478.046,481.901,485.684,488.278,491.69100000000003,493.905,495.387,499.17,501.322,503.395,506.58,509.765,513.178,516.961,520.745,524.45" y="626.463" svg_rhmargin="527.043" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">28. Lei Y, Huang Q, Huang Z, Xie J, Chen G, Pei F. Multiple-dose intravenous</text>
  <text x="319.747,321.899,323.972,327.157,330.941,334.353,337.396,340.581,346.366,347.848,350.962,353.082,356.267,359.38,360.862,364.71700000000004,366.858,368.71,372.415,374.489,376.64,380.424,383.837,385.90999999999997,388.061,390.134,393.547,397.402,401.107,404.22,407.633,410.226,412.382,416.165,417.647,421.502,425.356,428.769,432.552,434.718,438.573,440.055,443.838,447.622,451.47700000000003,453.597,455.079,458.862,461.455,464.048,466.239,469.424,471.276,473.428,476.841,478.914,481.035,483.187,486.97,489.122,492.307,493.78900000000004,495.945,499.728,501.21" y="635.477" svg_rhmargin="505.065" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">tranexamic acid further reduces hidden blood loss after total hip</text>
  <text x="319.747,322.932,325.006,327.157,330.941,333.014,336.797,340.652,342.134,345.319,347.912,350.064,353.177,354.36,356.483,359.668,361.813,363.886,367.071,370.854,374.709,378.492,384.278,385.76,388.574,391.987,395.84200000000004,398.039,401.152,404.936,408.719,410.871,412.944,416.727,418.209,419.691,423.104,426.959,429.106,431.258,433.331,434.813,437.998,439.48,440.663,442.826,445.27000000000004,447.362,451.515,453.589,455.74,459.524,461.597,465.38,469.235,470.717,473.902,476.495,478.647,479.83,482.0,485.413,488.826,492.239,495.651,496.834,500.247,503.66,505.512,508.925,510.778,511.96,515.373,518.786,522.199" y="644.491" svg_rhmargin="525.612" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">arthroplasty: a randomized controlled trial. J Arthroplast. 2018;33(9):2940</text>
  <text x="525.656" y="644.491" svg_rhmargin="529.218" style="fill:#131413;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="529.228,532.641" y="644.491" svg_rhmargin="533.824" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">5.</text>
  <text x="304.724,308.137,311.549,312.73199999999997,319.747,323.602,325.084,328.497,330.632,333.076,334.259,336.415,340.868,344.573,346.676,351.421,352.604,354.783,360.269,363.454,365.554,367.998,369.181,371.337,375.79,379.495,382.68,386.463,390.31800000000004,392.483,397.228,398.411,400.533,404.096,407.508,408.99,411.134,414.398,415.581,417.711,423.197,426.902,428.384,430.535,432.017,435.872,437.354,440.767,442.938,446.793,450.576,452.058,455.763,458.357,461.77,464.363,466.522,470.305,472.157,474.289,475.771,479.554,481.706,483.779,486.964,490.149,493.562,497.345,501.128,504.833" y="653.448" svg_rhmargin="507.426" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">29. Xie J, Hu Q, Ma J, Huang Q, Pei F. Multiple boluses of intravenous</text>
  <text x="319.747,321.899,323.972,327.157,330.941,334.353,337.396,340.581,346.366,347.848,350.962,353.082,356.267,359.38,360.862,364.71700000000004,366.858,369.01,372.793,374.965,377.039,380.452,384.306,388.011,391.125,394.538,396.679,400.462,401.944,405.798,409.653,413.066,416.849,419.015,422.87,424.352,428.135,431.918,435.773,437.893,439.375,443.159,445.752,448.345,450.479,453.664,457.447,461.302,463.461,465.613,469.396,472.809,474.97,476.452,480.235,482.088,483.57,486.754,492.54,498.325,501.51,503.662,507.445,509.519" y="662.462" svg_rhmargin="512.633" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">tranexamic acid to reduce hidden blood loss and the inflammatory</text>
  <text x="319.747,321.821,325.234,327.827,331.682,335.465,339.248,341.842,345.255,347.356,349.209,352.992,354.474,355.956,359.739,364.855,366.337,370.12,373.975,376.156,379.569,383.352,387.135,390.32,394.104,397.217,400.63,404.485,406.558,408.631,412.044,415.158,418.941,422.126,425.539,427.612,430.726,432.904,436.759,438.832,440.314,446.1,449.285,451.358,454.472,456.602,458.754,462.537,464.689,467.874,469.35600000000005,471.512,475.296,476.777,480.632,482.794,485.979,488.052,490.204,493.987,496.06,499.844,503.698,505.18,508.365,510.958,513.11,516.224,517.407,519.53" y="671.477" svg_rhmargin="522.715" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">response following enhanced-recovery primary total hip arthroplasty: a</text>
  <text x="319.747,321.821,325.006,328.789,332.643,336.427,342.212,343.694,346.288,349.7,353.555,355.69,358.803,360.285,361.767,365.551,367.032,370.146,373.331,374.81300000000005,376.949,379.101,381.174,382.656,385.841,387.323,388.506,390.669,394.231,398.014,401.798,405.211,407.336,409.78,413.563,415.045,418.828,420.97999999999996,423.153,425.597,426.78,428.936,432.349,435.761,439.174,442.587,443.77,447.183,450.596,452.669,456.523,458.376,461.789,465.202,467.054,468.237,471.65,475.063,478.475" y="680.491" svg_rhmargin="481.888" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">randomised clinical trial. Bone Joint J. 2017;99-b(11):1442</text>
  <text x="481.889" y="680.491" svg_rhmargin="485.451" style="fill:#131413;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="485.461,488.874" y="680.491" svg_rhmargin="490.057" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">9.</text>
  <text svg_rhmargin="497.732" x="304.724,308.137,311.549,312.73199999999997,319.747,325.417,329.12199999999996,330.973,334.715,339.31,340.493,342.255,346.708,350.413,352.176,355.66,357.902,359.085,360.964,364.227,367.71,371.493,373.379,376.942,380.295,381.478,383.3,387.304,390.897,394.309,398.09200000000004,399.854,403.416,404.599,406.373,410.826,414.31,417.495,421.113,424.968,426.84,432.509,433.692,435.513,438.698,441.977,444.128,446.058,449.471,451.544,453.315,455.467,459.25,460.969,463.12,466.751,470.164,471.967,475.38,479.11,480.471,482.623,486.254,488.327,490.165,493.949,497.732" y="689.448" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">30. Wu XD, Hu KJ, Sun YY, Chen Y, Huang W. Letter to the editor on </text>
  <text x="499.464" y="689.448" svg_rhmargin="501.537" style="fill:#131413;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">“</text>
  <text x="501.449,503.6,507.175,510.588,512.447,515.041,518.06,519.912,523.162,525.314,528.428,530.135,533.918" y="689.448" svg_rhmargin="535.77" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">the safety of</text>
  <text x="319.747,321.899,323.772,326.957,330.575,333.863,336.906,339.929,345.715,347.016,350.13,352.005,355.066,358.18,359.488,363.343,365.214,366.575,370.358,372.187,374.339,377.97,380.122,383.129,384.61100000000005,386.417,387.899,391.519,393.001,396.622,398.774,400.59,403.775,405.692,407.844,411.419,413.492,417.088,420.942,422.247,425.432,427.859,430.011,432.961,434.144,435.966,439.151,441.012,444.754,446.236,448.155,451.568,454.505,456.657,458.474,464.259,467.487,469.639,472.647,474.72,477.749,481.532,484.552,486.034,488.973,491.567,492.885" y="698.462" svg_rhmargin="495.478" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">tranexamic acid in total joint arthroplasty: a direct meta-analysis</text>
  <text x="495.383" y="698.462" svg_rhmargin="497.456" style="fill:#131413;font-family:FCMIFL+WvhqlrAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">”</text>
  <text x="497.367,498.55,500.371,502.815,504.68,508.834,510.746,512.898,516.471,518.545,522.141,525.995,527.3,530.485,532.912,535.064" y="698.462" svg_rhmargin="536.247" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">. J Arthroplast.</text>
  <text x="319.747,323.035,326.448,329.669,333.082,334.091,335.943,339.023,342.878,346.45,350.305,352.119,355.304,358.922,362.335,365.328,369.183,371.055,374.838,376.69,378.425,382.167,384.24,385.568,389.351,391.294,393.146" y="707.476" svg_rhmargin="394.329" style="fill:#131413;font-family:FCMIFJ+FjrmrtAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">2018;[Epub ahead of print].</text>
  <text svg_rhmargin="115.039" x="56.693,63.437,67.269,71.685,76.101,78.463,82.295,86.711,91.207,93.544,97.96,102.376,106.207,110.623,115.039" y="48.13900000000001" style="fill:#131413;font-family:FCMIFI+GghxhkAdvTTe45e47d2;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Wang and Zhang </text>
  <text svg_rhmargin="264.355" x="117.411,120.242,124.402,128.562,131.058,135.306,139.466,141.21,143.546,147.706,149.95399999999998,152.333,157.661,160.157,162.653,166.901,171.061,175.221,179.381,182.957,187.117,188.787,192.115,194.514,198.177,202.337,204.833,208.993,212.569,215.065,218.561,220.932,225.092,229.34,233.5,235.899,240.059,243.635,246.547,250.123,254.283,256.779,260.107,264.355" y="48.13900000000001" style="fill:#131413;font-family:FCMJCJ+TlfdkfAdvTT7329fd89.I;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Journal of Orthopaedic Surgery and Research </text>
  <text svg_rhmargin="314.906" y="48.13900000000001" x="268.378,270.65,274.754,278.858,282.962,287.066,289.338,291.034,295.138,299.242,300.898,305.002,309.106,313.21,314.906" style="fill:#131413;font-family:MyriadPro-Regular;font-size:8.0px;font-style:NORMAL;font-weight:normal;">(2018) 13:242 </text>
  <text x="491.979,496.227,500.059,504.474,508.474,510.858,514.938,519.018,521.402,525.73,528.058,530.417,534.497" y="48.13900000000001" svg_rhmargin="538.577" style="fill:#131413;font-family:FCMIFI+GghxhkAdvTTe45e47d2;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Page 11 of 11</text>
 </g>
</svg>
